<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1991-05-01" modified="2017-05-10" version="226">
<accession>P21802</accession>
<accession>B4DFC2</accession>
<accession>E7EVR6</accession>
<accession>E9PCR0</accession>
<accession>P18443</accession>
<accession>Q01742</accession>
<accession>Q12922</accession>
<accession>Q14300</accession>
<accession>Q14301</accession>
<accession>Q14302</accession>
<accession>Q14303</accession>
<accession>Q14304</accession>
<accession>Q14305</accession>
<accession>Q14672</accession>
<accession>Q14718</accession>
<accession>Q14719</accession>
<accession>Q1KHY5</accession>
<accession>Q86YI4</accession>
<accession>Q8IXC7</accession>
<accession>Q96KL9</accession>
<accession>Q96KM0</accession>
<accession>Q96KM1</accession>
<accession>Q96KM2</accession>
<accession>Q9NZU2</accession>
<accession>Q9NZU3</accession>
<accession>Q9UD01</accession>
<accession>Q9UD02</accession>
<accession>Q9UIH3</accession>
<accession>Q9UIH4</accession>
<accession>Q9UIH5</accession>
<accession>Q9UIH6</accession>
<accession>Q9UIH7</accession>
<accession>Q9UIH8</accession>
<accession>Q9UM87</accession>
<accession>Q9UMC6</accession>
<accession>Q9UNS7</accession>
<accession>Q9UQH7</accession>
<accession>Q9UQH8</accession>
<accession>Q9UQH9</accession>
<accession>Q9UQI0</accession>
<name>FGFR2_HUMAN</name>
<protein>
<recommendedName>
<fullName>Fibroblast growth factor receptor 2</fullName>
<shortName>FGFR-2</shortName>
<ecNumber evidence="47 53 58 59">2.7.10.1</ecNumber>
</recommendedName>
<alternativeName>
<fullName>K-sam</fullName>
<shortName>KGFR</shortName>
</alternativeName>
<alternativeName>
<fullName>Keratinocyte growth factor receptor</fullName>
</alternativeName>
<cdAntigenName>CD332</cdAntigenName>
</protein>
<gene>
<name type="primary">FGFR2</name>
<name type="synonym">BEK</name>
<name type="synonym">KGFR</name>
<name type="synonym">KSAM</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1990" name="EMBO J." volume="9" first="2685" last="2692">
<title>Cloning and expression of two distinct high-affinity receptors cross-reacting with acidic and basic fibroblast growth factors.</title>
<authorList>
<person name="Dionne C.A."/>
<person name="Crumley G.R."/>
<person name="Bellot F."/>
<person name="Kaplow J.M."/>
<person name="Searfoss G."/>
<person name="Ruta M."/>
<person name="Burgess W.H."/>
<person name="Jaye M."/>
<person name="Schlessinger J."/>
</authorList>
<dbReference type="PubMed" id="1697263"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Neonatal brain stem</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1990" name="Proc. Natl. Acad. Sci. U.S.A." volume="87" first="8180" last="8184">
<title>Related fibroblast growth factor receptor genes exist in the human genome.</title>
<authorList>
<person name="Houssaint E."/>
<person name="Blanquet P.R."/>
<person name="Champion-Arnaud P."/>
<person name="Gesnel M.-C."/>
<person name="Torriglia A."/>
<person name="Courtois Y."/>
<person name="Breathnach R."/>
</authorList>
<dbReference type="PubMed" id="2172978"/>
<dbReference type="DOI" id="10.1073/pnas.87.20.8180"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 16)</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1991" name="Biochim. Biophys. Acta" volume="1089" first="244" last="246">
<title>Two cDNAs encoding novel human FGF receptor.</title>
<authorList>
<person name="Seno M."/>
<person name="Sasada R."/>
<person name="Watanabe T."/>
<person name="Ishimaru K."/>
<person name="Igarashi K."/>
</authorList>
<dbReference type="PubMed" id="1647213"/>
<dbReference type="DOI" id="10.1016/0167-4781(91)90015-E"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 17)</scope>
</reference>
<reference key="4">
<citation type="journal article" date="1990" name="Proc. Natl. Acad. Sci. U.S.A." volume="87" first="5983" last="5987">
<title>K-sam, an amplified gene in stomach cancer, is a member of the heparin-binding growth factor receptor genes.</title>
<authorList>
<person name="Hattori Y."/>
<person name="Odagiri H."/>
<person name="Nakatani H."/>
<person name="Miyagawa K."/>
<person name="Naito K."/>
<person name="Sakamoto H."/>
<person name="Katoh O."/>
<person name="Yoshida T."/>
<person name="Sugimura T."/>
<person name="Terada M."/>
</authorList>
<dbReference type="PubMed" id="2377625"/>
<dbReference type="DOI" id="10.1073/pnas.87.15.5983"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4)</scope>
<source>
<tissue>Stomach cancer</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="1992" name="Proc. Natl. Acad. Sci. U.S.A." volume="89" first="2960" last="2964">
<title>K-sam gene encodes secreted as well as transmembrane receptor tyrosine kinase.</title>
<authorList>
<person name="Katoh M."/>
<person name="Hattori Y."/>
<person name="Sasaki H."/>
<person name="Tanaka M."/>
<person name="Sugano K."/>
<person name="Yazaki Y."/>
<person name="Sugimura T."/>
<person name="Terada M."/>
</authorList>
<dbReference type="PubMed" id="1313574"/>
<dbReference type="DOI" id="10.1073/pnas.89.7.2960"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 5; 14 AND 15)</scope>
</reference>
<reference key="6">
<citation type="journal article" date="1992" name="J. Biol. Chem." volume="267" first="21225" last="21229">
<title>A novel form of fibroblast growth factor receptor 2. Alternative splicing of the third immunoglobulin-like domain confers ligand binding specificity.</title>
<authorList>
<person name="Dell K.R."/>
<person name="Williams L.T."/>
</authorList>
<dbReference type="PubMed" id="1400433"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3)</scope>
<scope>DOMAIN</scope>
<scope>SUBUNIT</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="1992" name="Proc. Natl. Acad. Sci. U.S.A." volume="89" first="246" last="250">
<title>Determination of ligand-binding specificity by alternative splicing: two distinct growth factor receptors encoded by a single gene.</title>
<authorList>
<person name="Miki T."/>
<person name="Bottaro D.P."/>
<person name="Fleming T.P."/>
<person name="Smith C.L."/>
<person name="Burgess W.H."/>
<person name="Chan A.M.-L."/>
<person name="Aaronson S.A."/>
</authorList>
<dbReference type="PubMed" id="1309608"/>
<dbReference type="DOI" id="10.1073/pnas.89.1.246"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 3 AND 19)</scope>
<scope>SUBUNIT</scope>
<scope>DOMAIN</scope>
<scope>VARIANT ARG-613</scope>
<source>
<tissue>Mammary gland</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="1994" name="Cell. Mol. Biol. Res." volume="40" first="337" last="350">
<title>Hepatocyte growth factor (HGF), keratinocyte growth factor (KGF), and their receptors in human breast cells and tissues: alternative receptors.</title>
<authorList>
<person name="Wilson S.E."/>
<person name="Weng J."/>
<person name="Chwang E.L."/>
<person name="Gollahon L."/>
<person name="Leitch A.M."/>
<person name="Shay J.W."/>
</authorList>
<dbReference type="PubMed" id="7866434"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 19)</scope>
<source>
<tissue>Cornea</tissue>
<tissue>Mammary gland</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="1994" name="Cell. Mol. Biol. Res." volume="40" first="707" last="707">
<authorList>
<person name="Wilson S.E."/>
<person name="Weng J."/>
<person name="Chwang E.L."/>
<person name="Gollahon L."/>
<person name="Leitch A.M."/>
<person name="Shay J.W."/>
</authorList>
</citation>
<scope>ERRATUM</scope>
</reference>
<reference key="10">
<citation type="submission" date="1996-04" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Steinberger D."/>
<person name="Mueller U."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>VARIANT CS SER-342</scope>
<source>
<tissue>Blood</tissue>
</source>
</reference>
<reference key="11">
<citation type="journal article" date="1999" name="Cancer Res." volume="59" first="6080" last="6086">
<title>Deletion of the carboxyl-terminal exons of K-sam/FGFR2 by short homology-mediated recombination, generating preferential expression of specific messenger RNAs.</title>
<authorList>
<person name="Ueda T."/>
<person name="Sasaki H."/>
<person name="Kuwahara Y."/>
<person name="Nezu M."/>
<person name="Shibuya T."/>
<person name="Sakamoto H."/>
<person name="Ishii H."/>
<person name="Yanagihara K."/>
<person name="Mafune K."/>
<person name="Makuuchi M."/>
<person name="Terada M."/>
</authorList>
<dbReference type="PubMed" id="10626794"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 7; 9; 10; 11; 12 AND 13)</scope>
<scope>VARIANT ARG-613</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2001" name="Cytogenet. Cell Genet." volume="94" first="121" last="126">
<title>Fibroblast growth factor receptor 2 (FGFR2): genomic sequence and variations.</title>
<authorList>
<person name="Ingersoll R.G."/>
<person name="Paznekas W.A."/>
<person name="Tran A.K."/>
<person name="Scott A.F."/>
<person name="Jiang G."/>
<person name="Jabs E.W."/>
</authorList>
<dbReference type="PubMed" id="11856867"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS 5; 6; 8; 14 AND 18)</scope>
</reference>
<reference key="13">
<citation type="submission" date="2002-02" db="EMBL/GenBank/DDBJ databases">
<title>Sequence and polymorphisms in fibroblast growth factor receptor 2 (FGFR2) gene in humans.</title>
<authorList>
<person name="Lind D.L."/>
<person name="Cox D.R."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 3)</scope>
</reference>
<reference key="14">
<citation type="submission" date="2002-04" db="EMBL/GenBank/DDBJ databases">
<title>Identification of a novel variant of FGFR2.</title>
<authorList>
<person name="Jang J."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 23)</scope>
</reference>
<reference key="15">
<citation type="submission" date="2006-04" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NIEHS SNPs program"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANTS PRO-6 AND THR-186</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 21)</scope>
<source>
<tissue>Cerebellum</tissue>
</source>
</reference>
<reference key="17">
<citation type="journal article" date="2004" name="Nature" volume="429" first="375" last="381">
<title>The DNA sequence and comparative analysis of human chromosome 10.</title>
<authorList>
<person name="Deloukas P."/>
<person name="Earthrowl M.E."/>
<person name="Grafham D.V."/>
<person name="Rubenfield M."/>
<person name="French L."/>
<person name="Steward C.A."/>
<person name="Sims S.K."/>
<person name="Jones M.C."/>
<person name="Searle S."/>
<person name="Scott C."/>
<person name="Howe K."/>
<person name="Hunt S.E."/>
<person name="Andrews T.D."/>
<person name="Gilbert J.G.R."/>
<person name="Swarbreck D."/>
<person name="Ashurst J.L."/>
<person name="Taylor A."/>
<person name="Battles J."/>
<person name="Bird C.P."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ashwell R.I.S."/>
<person name="Ambrose K.D."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Banerjee R."/>
<person name="Bates K."/>
<person name="Beasley H."/>
<person name="Bray-Allen S."/>
<person name="Brown A.J."/>
<person name="Brown J.Y."/>
<person name="Burford D.C."/>
<person name="Burrill W."/>
<person name="Burton J."/>
<person name="Cahill P."/>
<person name="Camire D."/>
<person name="Carter N.P."/>
<person name="Chapman J.C."/>
<person name="Clark S.Y."/>
<person name="Clarke G."/>
<person name="Clee C.M."/>
<person name="Clegg S."/>
<person name="Corby N."/>
<person name="Coulson A."/>
<person name="Dhami P."/>
<person name="Dutta I."/>
<person name="Dunn M."/>
<person name="Faulkner L."/>
<person name="Frankish A."/>
<person name="Frankland J.A."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Gribble S."/>
<person name="Griffiths C."/>
<person name="Grocock R."/>
<person name="Gustafson E."/>
<person name="Hammond S."/>
<person name="Harley J.L."/>
<person name="Hart E."/>
<person name="Heath P.D."/>
<person name="Ho T.P."/>
<person name="Hopkins B."/>
<person name="Horne J."/>
<person name="Howden P.J."/>
<person name="Huckle E."/>
<person name="Hynds C."/>
<person name="Johnson C."/>
<person name="Johnson D."/>
<person name="Kana A."/>
<person name="Kay M."/>
<person name="Kimberley A.M."/>
<person name="Kershaw J.K."/>
<person name="Kokkinaki M."/>
<person name="Laird G.K."/>
<person name="Lawlor S."/>
<person name="Lee H.M."/>
<person name="Leongamornlert D.A."/>
<person name="Laird G."/>
<person name="Lloyd C."/>
<person name="Lloyd D.M."/>
<person name="Loveland J."/>
<person name="Lovell J."/>
<person name="McLaren S."/>
<person name="McLay K.E."/>
<person name="McMurray A."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Matthews L."/>
<person name="Milne S."/>
<person name="Nickerson T."/>
<person name="Nguyen M."/>
<person name="Overton-Larty E."/>
<person name="Palmer S.A."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Pelan S."/>
<person name="Phillimore B."/>
<person name="Porter K."/>
<person name="Rice C.M."/>
<person name="Rogosin A."/>
<person name="Ross M.T."/>
<person name="Sarafidou T."/>
<person name="Sehra H.K."/>
<person name="Shownkeen R."/>
<person name="Skuce C.D."/>
<person name="Smith M."/>
<person name="Standring L."/>
<person name="Sycamore N."/>
<person name="Tester J."/>
<person name="Thorpe A."/>
<person name="Torcasso W."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Tsolas J."/>
<person name="Wall M."/>
<person name="Walsh J."/>
<person name="Wang H."/>
<person name="Weinstock K."/>
<person name="West A.P."/>
<person name="Willey D.L."/>
<person name="Whitehead S.L."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Young L."/>
<person name="Chen Y."/>
<person name="Lovering R.C."/>
<person name="Moschonas N.K."/>
<person name="Siebert R."/>
<person name="Fechtel K."/>
<person name="Bentley D."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Doucette-Stamm L."/>
<person name="Beck S."/>
<person name="Smith D.R."/>
<person name="Rogers J."/>
</authorList>
<dbReference type="PubMed" id="15164054"/>
<dbReference type="DOI" id="10.1038/nature02462"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 20)</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="19">
<citation type="journal article" date="2000" name="Am. J. Hum. Genet." volume="66" first="768" last="777">
<title>Paternal origin of FGFR2 mutations in sporadic cases of Crouzon syndrome and Pfeiffer syndrome.</title>
<authorList>
<person name="Glaser R.L."/>
<person name="Jiang W."/>
<person name="Boyadjiev S.A."/>
<person name="Tran A.K."/>
<person name="Zachary A.A."/>
<person name="Van Maldergem L."/>
<person name="Johnson D."/>
<person name="Walsh S."/>
<person name="Oldridge M."/>
<person name="Wall S.A."/>
<person name="Wilkie A.O.M."/>
<person name="Jabs E.W."/>
</authorList>
<dbReference type="PubMed" id="10712195"/>
<dbReference type="DOI" id="10.1086/302831"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 314-427</scope>
</reference>
<reference key="20">
<citation type="journal article" date="1999" name="Gene" volume="230" first="69" last="79">
<title>Genomic organization of the human fibroblast growth factor receptor 2 (FGFR2) gene and comparative analysis of the human FGFR gene family.</title>
<authorList>
<person name="Zhang Y."/>
<person name="Gorry M.C."/>
<person name="Post J.C."/>
<person name="Ehrlich G.D."/>
</authorList>
<dbReference type="PubMed" id="10196476"/>
<dbReference type="DOI" id="10.1016/S0378-1119(99)00047-5"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-209; 212-767 AND 771-821 (ISOFORMS 5; 14 AND 18)</scope>
</reference>
<reference key="21">
<citation type="journal article" date="1995" name="Am. J. Hum. Genet." volume="57" first="321" last="328">
<title>Analysis of phenotypic features and FGFR2 mutations in Apert syndrome.</title>
<authorList>
<person name="Park W.-J."/>
<person name="Theda C."/>
<person name="Maestri N.E."/>
<person name="Meyers G.A."/>
<person name="Fryburg J.S."/>
<person name="Dufresne C."/>
<person name="Cohen M.M. Jr."/>
<person name="Jabs E.W."/>
</authorList>
<dbReference type="PubMed" id="7668257"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 249-313</scope>
<scope>VARIANTS APRS TRP-252 AND ARG-253</scope>
</reference>
<reference key="22">
<citation type="journal article" date="1996" name="Rinsho Byori" volume="44" first="435" last="438">
<title>Nucleotide sequences at intron 6 and exon 7 junction of fibroblast growth factor receptor 2 and rapid mutational analysis in Apert syndrome.</title>
<authorList>
<person name="Wada C."/>
<person name="Ishigaki M."/>
<person name="Toyo-oka Y."/>
<person name="Yamabe H."/>
<person name="Ohnuki Y."/>
<person name="Takada F."/>
<person name="Yamazaki Y."/>
<person name="Ohtani H."/>
</authorList>
<dbReference type="PubMed" id="8676562"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 251-259</scope>
</reference>
<reference key="23">
<citation type="journal article" date="1996" name="Nat. Genet." volume="13" first="48" last="53">
<title>Exclusive paternal origin of new mutations in Apert syndrome.</title>
<authorList>
<person name="Moloney D.M."/>
<person name="Slaney S.F."/>
<person name="Oldridge M."/>
<person name="Wall S.A."/>
<person name="Sahlin P."/>
<person name="Stenman G."/>
<person name="Wilkie A.O.M."/>
</authorList>
<dbReference type="PubMed" id="8673103"/>
<dbReference type="DOI" id="10.1038/ng0596-48"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 251-318</scope>
</reference>
<reference key="24">
<citation type="journal article" date="1995" name="Hum. Mol. Genet." volume="4" first="1387" last="1390">
<title>Crouzon syndrome: mutations in two spliceoforms of FGFR2 and a common point mutation shared with Jackson-Weiss syndrome.</title>
<authorList>
<person name="Gorry M.C."/>
<person name="Preston R.A."/>
<person name="White G.J."/>
<person name="Zhang Y."/>
<person name="Singhal V.K."/>
<person name="Losken H.W."/>
<person name="Parker M.G."/>
<person name="Nwokoro N.A."/>
<person name="Post J.C."/>
<person name="Ehrlich G.D."/>
</authorList>
<dbReference type="PubMed" id="7581378"/>
<dbReference type="DOI" id="10.1093/hmg/4.8.1387"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 263-361</scope>
<scope>VARIANTS CS PRO-289; ARG-338; SER-342; TYR-342; GLY-344 AND CYS-354</scope>
</reference>
<reference key="25">
<citation type="journal article" date="1996" name="Biochemistry" volume="35" first="15640" last="15645">
<title>Asparagine-344 is a key residue for ligand binding in keratinocyte growth factor receptor.</title>
<authorList>
<person name="Gray T.E."/>
<person name="Eisenstein M."/>
<person name="Yayon A."/>
<person name="Givol D."/>
</authorList>
<dbReference type="PubMed" id="8961926"/>
<dbReference type="DOI" id="10.1021/bi961942c"/>
</citation>
<scope>FUNCTION (ISOFORM 3)</scope>
<scope>SUBUNIT</scope>
<scope>DOMAIN</scope>
</reference>
<reference key="26">
<citation type="journal article" date="1996" name="J. Biol. Chem." volume="271" first="15292" last="15297">
<title>Receptor specificity of the fibroblast growth factor family.</title>
<authorList>
<person name="Ornitz D.M."/>
<person name="Xu J."/>
<person name="Colvin J.S."/>
<person name="McEwen D.G."/>
<person name="MacArthur C.A."/>
<person name="Coulier F."/>
<person name="Gao G."/>
<person name="Goldfarb M."/>
</authorList>
<dbReference type="PubMed" id="8663044"/>
<dbReference type="DOI" id="10.1074/jbc.271.25.15292"/>
</citation>
<scope>INTERACTION WITH FGF1; FGF2; FGF3; FGF4; FGF6; FGF7 AND FGF9</scope>
<scope>FUNCTION IN CELL PROLIFERATION</scope>
</reference>
<reference key="27">
<citation type="journal article" date="1998" name="Am. J. Hum. Genet." volume="62" first="1370" last="1380">
<title>Genetic heterogeneity of Saethre-Chotzen syndrome, due to TWIST and FGFR mutations.</title>
<authorList>
<person name="Paznekas W.A."/>
<person name="Cunningham M.L."/>
<person name="Howard T.D."/>
<person name="Korf B.R."/>
<person name="Lipson M.H."/>
<person name="Grix A.W."/>
<person name="Feingold M."/>
<person name="Goldberg R."/>
<person name="Borochowitz Z."/>
<person name="Aleck K."/>
<person name="Mulliken J."/>
<person name="Yin M."/>
<person name="Jabs E.W."/>
</authorList>
<dbReference type="PubMed" id="9585583"/>
<dbReference type="DOI" id="10.1086/301855"/>
</citation>
<scope>INVOLVEMENT IN SCS</scope>
<scope>VARIANT SCS 269-VAL-VAL-270 DEL</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="10374" last="10380">
<title>p21-activated protein kinase 4 (PAK4) interacts with the keratinocyte growth factor receptor and participates in keratinocyte growth factor-mediated inhibition of oxidant-induced cell death.</title>
<authorList>
<person name="Lu Y."/>
<person name="Pan Z.-Z."/>
<person name="Devaux Y."/>
<person name="Ray P."/>
</authorList>
<dbReference type="PubMed" id="12529371"/>
<dbReference type="DOI" id="10.1074/jbc.M205875200"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF PAK4; REGULATION OF CELL PROLIFERATION AND APOPTOSIS</scope>
<scope>INTERACTION WITH GRB2 AND PAK4</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="36259" last="36267">
<title>Cbl-mediated degradation of Lyn and Fyn induced by constitutive fibroblast growth factor receptor-2 activation supports osteoblast differentiation.</title>
<authorList>
<person name="Kaabeche K."/>
<person name="Lemonnier J."/>
<person name="Le Mee S."/>
<person name="Caverzasio J."/>
<person name="Marie P.J."/>
</authorList>
<dbReference type="PubMed" id="15190072"/>
<dbReference type="DOI" id="10.1074/jbc.M402469200"/>
</citation>
<scope>FUNCTION IN OSTEOBLAST DIFFERENTIATION AND IN PHOSPHORYLATION OF CBL</scope>
<scope>INTERACTION WITH CBL</scope>
<scope>UBIQUITINATION</scope>
<scope>CHARACTERIZATION OF VARIANT APRS TRP-252</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2005" name="Biochem. Biophys. Res. Commun." volume="327" first="523" last="532">
<title>Tyrosine 769 of the keratinocyte growth factor receptor is required for receptor signaling but not endocytosis.</title>
<authorList>
<person name="Ceridono M."/>
<person name="Belleudi F."/>
<person name="Ceccarelli S."/>
<person name="Torrisi M.R."/>
</authorList>
<dbReference type="PubMed" id="15629145"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2004.12.031"/>
</citation>
<scope>FUNCTION IN CELL PROLIFERATION AND ACTIVATION OF SIGNALING PATHWAYS</scope>
<scope>MUTAGENESIS OF TYR-769</scope>
<scope>PHOSPHORYLATION AT TYR-769</scope>
<scope>INTERACTION WITH PLCG1</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="15694" last="15700">
<title>Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family.</title>
<authorList>
<person name="Zhang X."/>
<person name="Ibrahimi O.A."/>
<person name="Olsen S.K."/>
<person name="Umemori H."/>
<person name="Mohammadi M."/>
<person name="Ornitz D.M."/>
</authorList>
<dbReference type="PubMed" id="16597617"/>
<dbReference type="DOI" id="10.1074/jbc.M601252200"/>
</citation>
<scope>INTERACTION WITH FGF1; FGF7; FGF8; FGF9; FGF10; FGF19; FGF21; FGF22 AND FGF23</scope>
<scope>FUNCTION IN STIMULATION OF CELL PROLIFERATION</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="27292" last="27305">
<title>Intracellular retention, degradation, and signaling of glycosylation-deficient FGFR2 and craniosynostosis syndrome-associated FGFR2C278F.</title>
<authorList>
<person name="Hatch N.E."/>
<person name="Hudson M."/>
<person name="Seto M.L."/>
<person name="Cunningham M.L."/>
<person name="Bothwell M."/>
</authorList>
<dbReference type="PubMed" id="16844695"/>
<dbReference type="DOI" id="10.1074/jbc.M600448200"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF PLCG1 (ISOFORM 1)</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>AUTOPHOSPHORYLATION</scope>
<scope>GLYCOSYLATION</scope>
<scope>INTERACTION WITH PLCG1</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF ASN-265 AND 656-TYR-TYR-657</scope>
<scope>UBIQUITINATION</scope>
<scope>CHARACTERIZATION OF VARIANT PS PHE-278</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2007" name="J. Biol. Chem." volume="282" first="26687" last="26695">
<title>Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21.</title>
<authorList>
<person name="Kurosu H."/>
<person name="Choi M."/>
<person name="Ogawa Y."/>
<person name="Dickson A.S."/>
<person name="Goetz R."/>
<person name="Eliseenkova A.V."/>
<person name="Mohammadi M."/>
<person name="Rosenblatt K.P."/>
<person name="Kliewer S.A."/>
<person name="Kuro-o M."/>
</authorList>
<dbReference type="PubMed" id="17623664"/>
<dbReference type="DOI" id="10.1074/jbc.M704165200"/>
</citation>
<scope>INTERACTION WITH FGF19; FGF21 AND KLB</scope>
<scope>FUNCTION IN PHOSPHORYLATION OF FRS2 AND ACTIVATION OF MAP KINASES</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2007" name="J. Cell. Physiol." volume="212" first="148" last="156">
<title>Fibroblast growth factor receptor-induced phosphorylation of STAT1 at the Golgi apparatus without translocation to the nucleus.</title>
<authorList>
<person name="Citores L."/>
<person name="Bai L."/>
<person name="Sorensen V."/>
<person name="Olsnes S."/>
</authorList>
<dbReference type="PubMed" id="17311277"/>
<dbReference type="DOI" id="10.1002/jcp.21014"/>
</citation>
<scope>FUNCTION IN STAT1 PHOSPHORYLATION</scope>
<scope>GLYCOSYLATION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2008" name="Bone" volume="42" first="1032" last="1039">
<title>FGFR2-Cbl interaction in lipid rafts triggers attenuation of PI3K/Akt signaling and osteoblast survival.</title>
<authorList>
<person name="Dufour C."/>
<person name="Guenou H."/>
<person name="Kaabeche K."/>
<person name="Bouvard D."/>
<person name="Sanjay A."/>
<person name="Marie P.J."/>
</authorList>
<dbReference type="PubMed" id="18374639"/>
<dbReference type="DOI" id="10.1016/j.bone.2008.02.009"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2009" name="Cell. Signal." volume="21" first="1370" last="1378">
<title>Novel phosphotyrosine targets of FGFR2IIIb signaling.</title>
<authorList>
<person name="Luo Y."/>
<person name="Yang C."/>
<person name="Jin C."/>
<person name="Xie R."/>
<person name="Wang F."/>
<person name="McKeehan W.L."/>
</authorList>
<dbReference type="PubMed" id="19410646"/>
<dbReference type="DOI" id="10.1016/j.cellsig.2009.04.004"/>
</citation>
<scope>FUNCTION AS FGF7 RECEPTOR AND IN PHOSPHORYLATION OF PLCG1 AND FRS2</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>PHOSPHORYLATION AT TYR-466; TYR-586; TYR-588; TYR-656 AND TYR-657</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="6227" last="6240">
<title>Aberrant receptor internalization and enhanced FRS2-dependent signaling contribute to the transforming activity of the fibroblast growth factor receptor 2 IIIb C3 isoform.</title>
<authorList>
<person name="Cha J.Y."/>
<person name="Maddileti S."/>
<person name="Mitin N."/>
<person name="Harden T.K."/>
<person name="Der C.J."/>
</authorList>
<dbReference type="PubMed" id="19103595"/>
<dbReference type="DOI" id="10.1074/jbc.M803998200"/>
</citation>
<scope>FUNCTION IN FIBROBLAST PROLIFERATION; ACTIVATION OF MAP KINASES AND PHOSPHORYLATION OF PLCG1 AND FRS2</scope>
<scope>INTERACTION WITH PLCG1 AND FRS2</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF TYR-769</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2009" name="Mol. Cell. Proteomics" volume="8" first="1751" last="1764">
<title>Large-scale proteomics analysis of the human kinome.</title>
<authorList>
<person name="Oppermann F.S."/>
<person name="Gnad F."/>
<person name="Olsen J.V."/>
<person name="Hornberger R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Mann M."/>
<person name="Daub H."/>
</authorList>
<dbReference type="PubMed" id="19369195"/>
<dbReference type="DOI" id="10.1074/mcp.M800588-MCP200"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2011" name="J. Biol. Chem." volume="286" first="24443" last="24450">
<title>The Casitas B lineage lymphoma (Cbl) mutant G306E enhances osteogenic differentiation in human mesenchymal stromal cells in part by decreased Cbl-mediated platelet-derived growth factor receptor alpha and fibroblast growth factor receptor 2 ubiquitination.</title>
<authorList>
<person name="Severe N."/>
<person name="Miraoui H."/>
<person name="Marie P.J."/>
</authorList>
<dbReference type="PubMed" id="21596750"/>
<dbReference type="DOI" id="10.1074/jbc.M110.197525"/>
</citation>
<scope>FUNCTION</scope>
<scope>UBIQUITINATION</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2005" name="Cytokine Growth Factor Rev." volume="16" first="139" last="149">
<title>Cellular signaling by fibroblast growth factor receptors.</title>
<authorList>
<person name="Eswarakumar V.P."/>
<person name="Lax I."/>
<person name="Schlessinger J."/>
</authorList>
<dbReference type="PubMed" id="15863030"/>
<dbReference type="DOI" id="10.1016/j.cytogfr.2005.01.001"/>
</citation>
<scope>REVIEW ON LIGAND SPECIFICITY</scope>
<scope>ALTERNATIVE SPLICING</scope>
<scope>SIGNALING</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2009" name="J. Invest. Dermatol." volume="129" first="1861" last="1867">
<title>FGFR2 abnormalities underlie a spectrum of bone, skin, and cancer pathologies.</title>
<authorList>
<person name="Katoh M."/>
</authorList>
<dbReference type="PubMed" id="19387476"/>
<dbReference type="DOI" id="10.1038/jid.2009.97"/>
</citation>
<scope>REVIEW ON LIGAND SPECIFICITY</scope>
<scope>ALTERNATIVE SPLICING</scope>
<scope>SIGNALING</scope>
<scope>ROLE IN DISEASE</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2010" name="Nat. Rev. Cancer" volume="10" first="116" last="129">
<title>Fibroblast growth factor signalling: from development to cancer.</title>
<authorList>
<person name="Turner N."/>
<person name="Grose R."/>
</authorList>
<dbReference type="PubMed" id="20094046"/>
<dbReference type="DOI" id="10.1038/nrc2780"/>
</citation>
<scope>REVIEW ON FUNCTION IN FGF SIGNALING</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-780</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="44">
<citation type="journal article" date="2000" name="Cell" volume="101" first="413" last="424">
<title>Crystal structures of two FGF-FGFR complexes reveal the determinants of ligand-receptor specificity.</title>
<authorList>
<person name="Plotnikov A.N."/>
<person name="Hubbard S.R."/>
<person name="Schlessinger J."/>
<person name="Mohammadi M."/>
</authorList>
<dbReference type="PubMed" id="10830168"/>
<dbReference type="DOI" id="10.1016/S0092-8674(00)80851-X"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 147-366 IN COMPLEX WITH FGF2</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2000" name="Nature" volume="407" first="1029" last="1034">
<title>Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin.</title>
<authorList>
<person name="Pellegrini L."/>
<person name="Burke D.F."/>
<person name="von Delft F."/>
<person name="Mulloy B."/>
<person name="Blundell T.L."/>
</authorList>
<dbReference type="PubMed" id="11069186"/>
<dbReference type="DOI" id="10.1038/35039551"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 148-366 IN COMPLEX WITH FGF1 AND HEPARIN</scope>
<scope>INTERACTION WITH FGF1 AND HEPARIN</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2000" name="Proc. Natl. Acad. Sci. U.S.A." volume="97" first="49" last="54">
<title>Structural interactions of fibroblast growth factor receptor with its ligands.</title>
<authorList>
<person name="Stauber D.J."/>
<person name="DiGabriele A.D."/>
<person name="Hendrickson W.A."/>
</authorList>
<dbReference type="PubMed" id="10618369"/>
<dbReference type="DOI" id="10.1073/pnas.97.1.49"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 147-362 IN COMPLEX WITH FGF1</scope>
</reference>
<reference key="47">
<citation type="journal article" date="2001" name="Proc. Natl. Acad. Sci. U.S.A." volume="98" first="7182" last="7187">
<title>Structural basis for fibroblast growth factor receptor 2 activation in Apert syndrome.</title>
<authorList>
<person name="Ibrahimi O.A."/>
<person name="Eliseenkova A.V."/>
<person name="Plotnikov A.N."/>
<person name="Yu K."/>
<person name="Ornitz D.M."/>
<person name="Mohammadi M."/>
</authorList>
<dbReference type="PubMed" id="11390973"/>
<dbReference type="DOI" id="10.1073/pnas.121183798"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 147-366 OF VARIANTS APRS TRP-252 AND ARG-253 IN COMPLEX WITH FGF2</scope>
</reference>
<reference key="48">
<citation type="journal article" date="2003" name="Proc. Natl. Acad. Sci. U.S.A." volume="100" first="2266" last="2271">
<title>Structural basis by which alternative splicing confers specificity in fibroblast growth factor receptors.</title>
<authorList>
<person name="Yeh B.K."/>
<person name="Igarashi M."/>
<person name="Eliseenkova A.V."/>
<person name="Plotnikov A.N."/>
<person name="Sher I."/>
<person name="Ron D."/>
<person name="Aaronson S.A."/>
<person name="Mohammadi M."/>
</authorList>
<dbReference type="PubMed" id="12591959"/>
<dbReference type="DOI" id="10.1073/pnas.0436500100"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) OF 140-371 IN COMPLEX WITH FGF10</scope>
</reference>
<reference key="49">
<citation type="journal article" date="2006" name="Genes Dev." volume="20" first="185" last="198">
<title>Structural basis by which alternative splicing modulates the organizer activity of FGF8 in the brain.</title>
<authorList>
<person name="Olsen S.K."/>
<person name="Li J.Y.H."/>
<person name="Bromleigh C."/>
<person name="Eliseenkova A.V."/>
<person name="Ibrahimi O.A."/>
<person name="Lao Z."/>
<person name="Zhang F."/>
<person name="Linhardt R.J."/>
<person name="Joyner A.L."/>
<person name="Mohammadi M."/>
</authorList>
<dbReference type="PubMed" id="16384934"/>
<dbReference type="DOI" id="10.1101/gad.1365406"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.28 ANGSTROMS) OF 149-368 IN COMPLEX WITH FGF8</scope>
<scope>FUNCTION AS FGF8 RECEPTOR</scope>
<scope>INTERACTION WITH FGF8</scope>
<scope>DISULFIDE BONDS</scope>
</reference>
<reference key="50">
<citation type="journal article" date="2007" name="Mol. Cell" volume="27" first="717" last="730">
<title>A molecular brake in the kinase hinge region regulates the activity of receptor tyrosine kinases.</title>
<authorList>
<person name="Chen H."/>
<person name="Ma J."/>
<person name="Li W."/>
<person name="Eliseenkova A.V."/>
<person name="Xu C."/>
<person name="Neubert T.A."/>
<person name="Miller W.T."/>
<person name="Mohammadi M."/>
</authorList>
<dbReference type="PubMed" id="17803937"/>
<dbReference type="DOI" id="10.1016/j.molcel.2007.06.028"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS) OF 458-778 IN COMPLEX WITH ATP ANALOG; PEPTIDE SUBSTRATE AND MAGNESIUM</scope>
<scope>ENZYME REGULATION</scope>
<scope>PHOSPHORYLATION AT TYR-586; TYR-656 AND TYR-657</scope>
<scope>MUTAGENESIS OF ASN-549 AND GLU-565</scope>
<scope>CHARACTERIZATION OF VARIANT FSPC GLU-526</scope>
<scope>CHARACTERIZATION OF VARIANT CS HIS-549</scope>
<scope>CHARACTERIZATION OF VARIANTS PS GLY-565 AND ARG-641</scope>
<scope>CHARACTERIZATION OF VARIANT CRANIOSYNOSTOSIS ASN-659</scope>
</reference>
<reference key="51">
<citation type="journal article" date="2007" name="Proc. Natl. Acad. Sci. U.S.A." volume="104" first="19802" last="19807">
<title>Structural basis for reduced FGFR2 activity in LADD syndrome: Implications for FGFR autoinhibition and activation.</title>
<authorList>
<person name="Lew E.D."/>
<person name="Bae J.H."/>
<person name="Rohmann E."/>
<person name="Wollnik B."/>
<person name="Schlessinger J."/>
</authorList>
<dbReference type="PubMed" id="18056630"/>
<dbReference type="DOI" id="10.1073/pnas.0709905104"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS) OF 458-766 OF VARIANT LADDS THR-628 IN COMPLEX WITH ATP ANALOG</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>SUBUNIT</scope>
<scope>AUTOPHOSPHORYLATION</scope>
</reference>
<reference key="52">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="19660" last="19665">
<title>A crystallographic snapshot of tyrosine trans-phosphorylation in action.</title>
<authorList>
<person name="Chen H."/>
<person name="Xu C.F."/>
<person name="Ma J."/>
<person name="Eliseenkova A.V."/>
<person name="Li W."/>
<person name="Pollock P.M."/>
<person name="Pitteloud N."/>
<person name="Miller W.T."/>
<person name="Neubert T.A."/>
<person name="Mohammadi M."/>
</authorList>
<dbReference type="PubMed" id="19060208"/>
<dbReference type="DOI" id="10.1073/pnas.0807752105"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 458-778 IN COMPLEX WITH ATP</scope>
<scope>ACTIVE SITE</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>AUTOPHOSPHORYLATION</scope>
<scope>PHOSPHORYLATION AT TYR-466; TYR-586; TYR-588; TYR-656; TYR-657 AND TYR-769</scope>
</reference>
<reference key="53">
<citation type="journal article" date="2011" name="J. Biol. Chem." volume="286" first="20677" last="20687">
<title>A novel mode of protein kinase inhibition exploiting hydrophobic motifs of autoinhibited kinases: discovery of ATP-independent inhibitors of fibroblast growth factor receptor.</title>
<authorList>
<person name="Eathiraj S."/>
<person name="Palma R."/>
<person name="Hirschi M."/>
<person name="Volckova E."/>
<person name="Nakuci E."/>
<person name="Castro J."/>
<person name="Chen C.R."/>
<person name="Chan T.C."/>
<person name="France D.S."/>
<person name="Ashwell M.A."/>
</authorList>
<dbReference type="PubMed" id="21454610"/>
<dbReference type="DOI" id="10.1074/jbc.M110.213736"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.10 ANGSTROMS) OF 458-768 IN COMPLEX WITH INHIBITOR</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>AUTOPHOSPHORYLATION</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="54">
<citation type="journal article" date="1994" name="Nat. Genet." volume="8" first="98" last="103">
<title>Mutations in the fibroblast growth factor receptor 2 gene cause Crouzon syndrome.</title>
<authorList>
<person name="Reardon W."/>
<person name="Winter R.M."/>
<person name="Rutland P."/>
<person name="Pulleyn L.J."/>
<person name="Jones B.M."/>
<person name="Malcolm S."/>
</authorList>
<dbReference type="PubMed" id="7987400"/>
<dbReference type="DOI" id="10.1038/ng0994-98"/>
</citation>
<scope>VARIANTS CS HIS-340; ARG-342; SER-342; TYR-342 AND CYS-354</scope>
</reference>
<reference key="55">
<citation type="journal article" date="1994" name="Nat. Genet." volume="8" first="275" last="279">
<title>Jackson-Weiss and Crouzon syndromes are allelic with mutations in fibroblast growth factor receptor 2.</title>
<authorList>
<person name="Jabs E.W."/>
<person name="Li X."/>
<person name="Scott A.F."/>
<person name="Meyers G.A."/>
<person name="Chen W."/>
<person name="Eccles M."/>
<person name="Mao J."/>
<person name="Charnas L.R."/>
<person name="Jackson C.E."/>
<person name="Jaye M."/>
</authorList>
<dbReference type="PubMed" id="7874170"/>
<dbReference type="DOI" id="10.1038/ng1194-275"/>
</citation>
<scope>VARIANTS CS CYS-328 AND CYS-347</scope>
<scope>VARIANT JWS GLY-344</scope>
</reference>
<reference key="56">
<citation type="journal article" date="1995" name="Hum. Mol. Genet." volume="4" first="1077" last="1082">
<title>Mutations in the third immunoglobulin domain of the fibroblast growth factor receptor-2 gene in Crouzon syndrome.</title>
<authorList>
<person name="Oldridge M."/>
<person name="Wilkie A.O.M."/>
<person name="Slaney S.F."/>
<person name="Poole M.D."/>
<person name="Pulleyn L.J."/>
<person name="Rutland P."/>
<person name="Hockley A.D."/>
<person name="Wake M.J.C."/>
<person name="Goldin J.H."/>
<person name="Winter R.M."/>
<person name="Reardon W."/>
<person name="Malcolm S."/>
</authorList>
<dbReference type="PubMed" id="7655462"/>
<dbReference type="DOI" id="10.1093/hmg/4.6.1077"/>
</citation>
<scope>VARIANTS CS</scope>
</reference>
<reference key="57">
<citation type="journal article" date="1995" name="Hum. Mol. Genet." volume="4" first="1229" last="1233">
<title>Novel FGFR2 mutations in Crouzon and Jackson-Weiss syndromes show allelic heterogeneity and phenotypic variability.</title>
<authorList>
<person name="Park W.-J."/>
<person name="Meyers G.A."/>
<person name="Li X."/>
<person name="Theda C."/>
<person name="Day D."/>
<person name="Orlow S.J."/>
<person name="Jones M.C."/>
<person name="Jabs E.W."/>
</authorList>
<dbReference type="PubMed" id="8528214"/>
<dbReference type="DOI" id="10.1093/hmg/4.7.1229"/>
</citation>
<scope>VARIANTS CS GLY-290; TRP-342 AND CYS-354</scope>
<scope>VARIANT JWS ARG-342</scope>
</reference>
<reference key="58">
<citation type="journal article" date="1995" name="Nat. Genet." volume="9" first="108" last="108">
<title>FGFR2 mutations in Pfeiffer syndrome.</title>
<authorList>
<person name="Lajeunie E."/>
<person name="Wei M.H."/>
<person name="Bonaventure J."/>
<person name="Munnich A."/>
<person name="le Merrer M."/>
<person name="Renier D."/>
</authorList>
<dbReference type="PubMed" id="7719333"/>
<dbReference type="DOI" id="10.1038/ng0295-108"/>
</citation>
<scope>VARIANT PS ALA-321</scope>
</reference>
<reference key="59">
<citation type="journal article" date="1995" name="Nat. Genet." volume="9" first="165" last="172">
<title>Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome.</title>
<authorList>
<person name="Wilkie A.O.M."/>
<person name="Slaney S.F."/>
<person name="Oldridge M."/>
<person name="Poole M.D."/>
<person name="Ashworth G.J."/>
<person name="Hockley A.D."/>
<person name="Hayward R.D."/>
<person name="David D.J."/>
<person name="Pulleyn L.J."/>
<person name="Rutland P."/>
<person name="Malcolm S."/>
<person name="Winter R.M."/>
<person name="Reardon W."/>
</authorList>
<dbReference type="PubMed" id="7719344"/>
<dbReference type="DOI" id="10.1038/ng0295-165"/>
</citation>
<scope>VARIANTS APRS TRP-252 AND ARG-253</scope>
</reference>
<reference key="60">
<citation type="journal article" date="1995" name="Nat. Genet." volume="9" first="173" last="176">
<title>Identical mutations in the FGFR2 gene cause both Pfeiffer and Crouzon syndrome phenotypes.</title>
<authorList>
<person name="Rutland P."/>
<person name="Pulleyn L.J."/>
<person name="Reardon W."/>
<person name="Baraister M."/>
<person name="Hayward R."/>
<person name="Jones B.M."/>
<person name="Malcolm S."/>
<person name="Winter R.M."/>
<person name="Oldridge M."/>
<person name="Slaney S.F."/>
<person name="Poole M.D."/>
<person name="Wilkie A.O.M."/>
</authorList>
<dbReference type="PubMed" id="7719345"/>
<dbReference type="DOI" id="10.1038/ng0295-173"/>
</citation>
<scope>VARIANTS PS PRO-341; ARG-342 AND TYR-342</scope>
</reference>
<reference key="61">
<citation type="journal article" date="1996" name="Am. J. Hum. Genet." volume="58" first="491" last="498">
<title>FGFR2 exon IIIa and IIIc mutations in Crouzon, Jackson-Weiss, and Pfeiffer syndromes: evidence for missense changes, insertions, and a deletion due to alternative RNA splicing.</title>
<authorList>
<person name="Meyers G.A."/>
<person name="Day D."/>
<person name="Goldberg R."/>
<person name="Daentl D.L."/>
<person name="Przylepa K.A."/>
<person name="Abrams L.J."/>
<person name="Graham J.M. Jr."/>
<person name="Feingold M."/>
<person name="Moeschler J.B."/>
<person name="Rawnsley E."/>
<person name="Scott A.F."/>
<person name="Jabs E.W."/>
</authorList>
<dbReference type="PubMed" id="8644708"/>
</citation>
<scope>VARIANTS CS GLY-268 INS; PHE-342 AND TYR-342</scope>
<scope>VARIANTS PS PHE-278; ARG-342; SER-342; PRO-344 AND PHE-359</scope>
<scope>VARIANT JWS PRO-289</scope>
</reference>
<reference key="62">
<citation type="journal article" date="1996" name="Eur. J. Hum. Genet." volume="4" first="283" last="291">
<title>Spectrum of craniosynostosis phenotypes associated with novel mutations at the fibroblast growth factor receptor 2 locus.</title>
<authorList>
<person name="Pulleyn L.J."/>
<person name="Reardon W."/>
<person name="Wilkes D."/>
<person name="Rutland P."/>
<person name="Jones B.M."/>
<person name="Hayward R."/>
<person name="Hall C.M."/>
<person name="Brueton L."/>
<person name="Chun N."/>
<person name="Lammer E."/>
<person name="Malcolm S."/>
<person name="Winter R.M."/>
</authorList>
<dbReference type="PubMed" id="8946174"/>
</citation>
<scope>VARIANTS CS CYS-105; GLU-338; CYS-351 AND ARG-384</scope>
</reference>
<reference key="63">
<citation type="journal article" date="1996" name="Hum. Mutat." volume="8" first="386" last="390">
<title>Crouzon syndrome: previously unrecognized deletion, duplication, and point mutation within FGFR2 gene.</title>
<authorList>
<person name="Steinberger D."/>
<person name="Mulliken J.B."/>
<person name="Mueller U."/>
</authorList>
<dbReference type="PubMed" id="8956050"/>
<dbReference type="DOI" id="10.1002/(SICI)1098-1004(1996)8:4&lt;386::AID-HUMU18>3.3.CO;2-A"/>
</citation>
<scope>VARIANTS CS ILE-331; ASN-ALA-337 INS AND 356-TRP--THR-358 DEL</scope>
</reference>
<reference key="64">
<citation type="journal article" date="1996" name="Nat. Genet." volume="13" first="492" last="494">
<title>Fibroblast growth factor receptor 2 mutations in Beare-Stevenson cutis gyrata syndrome.</title>
<authorList>
<person name="Przylepa K.A."/>
<person name="Paznekas W.A."/>
<person name="Zhang M."/>
<person name="Golabi M."/>
<person name="Bias W."/>
<person name="Bamshad M.J."/>
<person name="Carey J.C."/>
<person name="Hall B.D."/>
<person name="Stevenson R."/>
<person name="Orlow S.J."/>
<person name="Cohen M.M. Jr."/>
<person name="Jabs E.W."/>
</authorList>
<dbReference type="PubMed" id="8696350"/>
<dbReference type="DOI" id="10.1038/ng0896-492"/>
</citation>
<scope>VARIANTS BSTVS CYS-372 AND CYS-375</scope>
</reference>
<reference key="65">
<citation type="journal article" date="1997" name="Hum. Genet." volume="99" first="602" last="606">
<title>Trp290Cys mutation in exon IIIa of the fibroblast growth factor receptor 2 (FGFR2) gene is associated with Pfeiffer syndrome.</title>
<authorList>
<person name="Tartaglia M."/>
<person name="Valeri S."/>
<person name="Velardi F."/>
<person name="di Rocco C."/>
<person name="Battaglia P.A."/>
</authorList>
<dbReference type="PubMed" id="9150725"/>
<dbReference type="DOI" id="10.1007/s004390050413"/>
</citation>
<scope>VARIANT PS CYS-290</scope>
</reference>
<reference key="66">
<citation type="journal article" date="1997" name="Hum. Genet." volume="101" first="47" last="50">
<title>Jackson-Weiss syndrome: identification of two novel FGFR2 missense mutations shared with Crouzon and Pfeiffer craniosynostotic disorders.</title>
<authorList>
<person name="Tartaglia M."/>
<person name="Di Rocco C."/>
<person name="Lajeunie E."/>
<person name="Valeri S."/>
<person name="Velardi F."/>
<person name="Battaglia P.A."/>
</authorList>
<dbReference type="PubMed" id="9385368"/>
<dbReference type="DOI" id="10.1007/s004390050584"/>
</citation>
<scope>VARIANT JWS SER-342</scope>
</reference>
<reference key="67">
<citation type="journal article" date="1997" name="Hum. Mol. Genet." volume="6" first="137" last="143">
<title>Genotype-phenotype correlation for nucleotide substitutions in the IgII-IgIII linker of FGFR2.</title>
<authorList>
<person name="Oldridge M."/>
<person name="Lunt P.W."/>
<person name="Zackai E.H."/>
<person name="McDonald-Mcginn D.M."/>
<person name="Muenke M."/>
<person name="Moloney D.M."/>
<person name="Twigg S.R.F."/>
<person name="Heath J.K."/>
<person name="Howard T.D."/>
<person name="Hoganson G."/>
<person name="Gagnon D.M."/>
<person name="Jabs E.W."/>
<person name="Wilkie A.O.M."/>
</authorList>
<dbReference type="PubMed" id="9002682"/>
<dbReference type="DOI" id="10.1093/hmg/6.1.137"/>
</citation>
<scope>VARIANT CS LEU-252</scope>
<scope>VARIANT APRS PHE-252</scope>
<scope>VARIANT PS 252-PHE-SER-253</scope>
</reference>
<reference key="68">
<citation type="journal article" date="1997" name="J. Med. Genet." volume="34" first="420" last="422">
<title>A novel mutation (a886g) in exon 5 of FGFR2 in members of a family with Crouzon phenotype and plagiocephaly.</title>
<authorList>
<person name="Steinberger D."/>
<person name="Collmann H."/>
<person name="Schmalenberger B."/>
<person name="Mueller U."/>
</authorList>
<dbReference type="PubMed" id="9152842"/>
<dbReference type="DOI" id="10.1136/jmg.34.5.420"/>
</citation>
<scope>VARIANT CS GLU-292</scope>
</reference>
<reference key="69">
<citation type="journal article" date="1998" name="Am. J. Med. Genet." volume="78" first="237" last="241">
<title>Description of a new mutation and characterization of FGFR1, FGFR2, and FGFR3 mutations among Brazilian patients with syndromic craniosynostoses.</title>
<authorList>
<person name="Passos-Bueno M.R."/>
<person name="Sertie A.L."/>
<person name="Richieri-Costa A."/>
<person name="Alonso L.G."/>
<person name="Zatz M."/>
<person name="Alonso N."/>
<person name="Brunoni D."/>
<person name="Ribeiro S.F.M."/>
</authorList>
<dbReference type="PubMed" id="9677057"/>
<dbReference type="DOI" id="10.1002/(SICI)1096-8628(19980707)78:3&lt;237::AID-AJMG5>3.3.CO;2-5"/>
</citation>
<scope>VARIANTS CS PHE-278; PRO-337; ARG-338; ARG-342; PHE-342 AND TYR-342</scope>
<scope>VARIANTS APRS TRP-252 AND ARG-253</scope>
<scope>VARIANT JWS PHE-278</scope>
</reference>
<reference key="70">
<citation type="journal article" date="1998" name="Hum. Genet." volume="102" first="145" last="150">
<title>The mutations in FGFR2-associated craniosynostoses are clustered in five structural elements of immunoglobulin-like domain III of the receptor.</title>
<authorList>
<person name="Steinberger D."/>
<person name="Vriend G."/>
<person name="Mulliken J.B."/>
<person name="Mueller U."/>
</authorList>
<dbReference type="PubMed" id="9521581"/>
<dbReference type="DOI" id="10.1007/s004390050668"/>
</citation>
<scope>VARIANTS CS VAL-276 AND CYS-301</scope>
<scope>VARIANT CRANIOSYNOSTOSIS SER-314</scope>
</reference>
<reference key="71">
<citation type="journal article" date="1998" name="Hum. Mutat. Suppl." volume="1" first="S18" last="S19">
<title>Two common mutations 934C to G and 937C to G of fibroblast growth factor receptor 2 (FGFR2) gene in Chinese patients with Apert syndrome.</title>
<authorList>
<person name="Tsai F.-J."/>
<person name="Hwu W.-L."/>
<person name="Lin S.-P."/>
<person name="Chang J.-G."/>
<person name="Wang T.-R."/>
<person name="Tsai C.-H."/>
</authorList>
<dbReference type="PubMed" id="9452027"/>
</citation>
<scope>VARIANTS APRS TRP-252 AND ARG-253</scope>
</reference>
<reference key="72">
<citation type="journal article" date="1998" name="J. Craniofac. Surg." volume="9" first="207" last="209">
<title>Pfeiffer's syndrome resulting from an S351C mutation in the fibroblast growth factor receptor-2 gene.</title>
<authorList>
<person name="Mathijssen I.M."/>
<person name="Vaandrager J.M."/>
<person name="Hoogeboom A.J."/>
<person name="Hesseling-Janssen A.L.W."/>
<person name="van den Ouweland A.M.W."/>
</authorList>
<dbReference type="PubMed" id="9693549"/>
</citation>
<scope>VARIANT PS CYS-351</scope>
</reference>
<reference key="73">
<citation type="journal article" date="1998" name="J. Med. Genet." volume="35" first="677" last="679">
<title>Presence of the Apert canonical S252W FGFR2 mutation in a patient without severe syndactyly.</title>
<authorList>
<person name="Passos-Bueno M.R."/>
<person name="Richieri-Costa A."/>
<person name="Sertie A.L."/>
<person name="Kneppers A."/>
</authorList>
<dbReference type="PubMed" id="9719378"/>
<dbReference type="DOI" id="10.1136/jmg.35.8.677"/>
</citation>
<scope>VARIANT PS TRP-252</scope>
</reference>
<reference key="74">
<citation type="journal article" date="1999" name="Cleft Palate Craniofac. J." volume="36" first="533" last="541">
<title>A novel FGFR2 gene mutation in Crouzon syndrome associated with apparent nonpenetrance.</title>
<authorList>
<person name="Everett E.T."/>
<person name="Britto D.A."/>
<person name="Ward R.E."/>
<person name="Hartsfield J.K. Jr."/>
</authorList>
<dbReference type="PubMed" id="10574673"/>
<dbReference type="DOI" id="10.1597/1545-1569(1999)036&lt;0533:ANFGMI>2.3.CO;2"/>
</citation>
<scope>VARIANT CS SER-362</scope>
</reference>
<reference key="75">
<citation type="journal article" date="1999" name="Hum. Genet." volume="104" first="425" last="431">
<title>Analysis of the mutational spectrum of the FGFR2 gene in Pfeiffer syndrome.</title>
<authorList>
<person name="Cornejo-Roldan L.R."/>
<person name="Roessler E."/>
<person name="Muenke M."/>
</authorList>
<dbReference type="PubMed" id="10394936"/>
<dbReference type="DOI" id="10.1007/s004390050979"/>
</citation>
<scope>VARIANTS PS CYS-340 AND GLY-342</scope>
</reference>
<reference key="76">
<citation type="journal article" date="2000" name="Clin. Genet." volume="58" first="81" last="83">
<title>Pfeiffer syndrome type 2 associated with a single amino acid deletion in the FGFR2 gene.</title>
<authorList>
<person name="Priolo M."/>
<person name="Lerone M."/>
<person name="Baffico M."/>
<person name="Baldi M."/>
<person name="Ravazzolo R."/>
<person name="Cama A."/>
<person name="Capra V."/>
<person name="Silengo M."/>
</authorList>
<dbReference type="PubMed" id="10945669"/>
<dbReference type="DOI" id="10.1034/j.1399-0004.2000.580116.x"/>
</citation>
<scope>VARIANT PS ASP-273 DEL</scope>
</reference>
<reference key="77">
<citation type="journal article" date="2000" name="Cytogenet. Cell Genet." volume="91" first="134" last="137">
<title>Clustering of FGFR2 gene mutations in patients with Pfeiffer and Crouzon syndromes (FGFR2-associated craniosynostoses).</title>
<authorList>
<person name="Kress W."/>
<person name="Collmann H."/>
<person name="Buesse M."/>
<person name="Halliger-Keller B."/>
<person name="Mueller C.R."/>
</authorList>
<dbReference type="PubMed" id="11173845"/>
</citation>
<scope>VARIANTS CS/PS ARG-342 AND TYR-342</scope>
<scope>VARIANTS CS LEU-263; VAL-276; PHE-278; TYR-278; SER-288; PRO-289; PRO-341; TRP-342; CYS-354; TYR-354 AND PHE-359</scope>
<scope>VARIANT PS SER-342</scope>
</reference>
<reference key="78">
<citation type="journal article" date="2000" name="Eur. J. Hum. Genet." volume="8" first="571" last="577">
<title>A novel mutation, Ala315Ser, in FGFR2: a gene-environment interaction leading to craniosynostosis?</title>
<authorList>
<person name="Johnson D."/>
<person name="Wall S.A."/>
<person name="Mann S."/>
<person name="Wilkie A.O.M."/>
</authorList>
<dbReference type="PubMed" id="10951518"/>
<dbReference type="DOI" id="10.1038/sj.ejhg.5200499"/>
</citation>
<scope>VARIANT SER-315</scope>
</reference>
<reference key="79">
<citation type="journal article" date="2000" name="J. Med. Genet." volume="37" first="26" last="32">
<title>Evidence for digenic inheritance in some cases of Antley-Bixler syndrome?</title>
<authorList>
<person name="Reardon W."/>
<person name="Smith A."/>
<person name="Honour J.W."/>
<person name="Hindmarsh P."/>
<person name="Das D."/>
<person name="Rumsby G."/>
<person name="Nelson I."/>
<person name="Malcolm S."/>
<person name="Ades L."/>
<person name="Sillence D."/>
<person name="Kumar D."/>
<person name="DeLozier-Blanchet C."/>
<person name="McKee S."/>
<person name="Kelly T."/>
<person name="McKeehan W.L."/>
<person name="Baraitser M."/>
<person name="Winter R.M."/>
</authorList>
<dbReference type="PubMed" id="10633130"/>
<dbReference type="DOI" id="10.1136/jmg.37.1.26"/>
</citation>
<scope>VARIANTS ABS2 ARG-342; SER-342 AND CYS-351</scope>
</reference>
<reference key="80">
<citation type="journal article" date="2001" name="Pediatr. Int." volume="43" first="263" last="266">
<title>Mutation analysis of Crouzon syndrome and identification of one novel mutation in Taiwanese patients.</title>
<authorList>
<person name="Tsai F.-J."/>
<person name="Yang C.-F."/>
<person name="Wu J.-Y."/>
<person name="Tsai C.-H."/>
<person name="Lee C.-C."/>
</authorList>
<dbReference type="PubMed" id="11380921"/>
<dbReference type="DOI" id="10.1046/j.1442-200x.2001.01392.x"/>
</citation>
<scope>VARIANTS CS CYS-281; PRO-289; ARG-342 AND TYR-342</scope>
</reference>
<reference key="81">
<citation type="journal article" date="2002" name="Am. J. Hum. Genet." volume="70" first="472" last="486">
<title>Genomic screening of fibroblast growth-factor receptor 2 reveals a wide spectrum of mutations in patients with syndromic craniosynostosis.</title>
<authorList>
<person name="Kan S.-H."/>
<person name="Elanko N."/>
<person name="Johnson D."/>
<person name="Cornejo-Roldan L.R."/>
<person name="Cook J."/>
<person name="Reich E.W."/>
<person name="Tomkins S."/>
<person name="Verloes A."/>
<person name="Twigg S.R.F."/>
<person name="Rannan-Eliya S."/>
<person name="McDonald-McGinn D.M."/>
<person name="Zackai E.H."/>
<person name="Wall S.A."/>
<person name="Muenke M."/>
<person name="Wilkie A.O.M."/>
</authorList>
<dbReference type="PubMed" id="11781872"/>
<dbReference type="DOI" id="10.1086/338758"/>
</citation>
<scope>VARIANTS CS CYS-105; PRO-267; VAL-276; CYS-281; PRO-289; ARG-338; HIS-340; PHE-342; TRP-342; CYS-347; CYS-354; HIS-549 AND GLY-678</scope>
<scope>VARIANTS PS PHE-172; 252-PHE-SER-253; CYS-290; CYS-340; PRO-341; ARG-342; SER-342; CYS-375; GLY-565; ARG-641 AND GLU-663</scope>
<scope>VARIANTS APRS TRP-252 AND ARG-253</scope>
<scope>VARIANTS CS/PS PHE-278 AND TYR-342</scope>
<scope>VARIANT CRANIOSYNOSTOSIS ASN-659</scope>
<scope>VARIANTS THR-186 AND SER-315</scope>
</reference>
<reference key="82">
<citation type="journal article" date="2002" name="Clin. Genet." volume="61" first="218" last="221">
<title>Mutation in the FGFR2 gene in a Taiwanese patient with Beare-Stevenson cutis gyrata syndrome.</title>
<authorList>
<person name="Wang T.-J."/>
<person name="Huang C.-B."/>
<person name="Tsai F.-J."/>
<person name="Wu J.-Y."/>
<person name="Lai R.-B."/>
<person name="Hsiao M."/>
</authorList>
<dbReference type="PubMed" id="12000365"/>
<dbReference type="DOI" id="10.1034/j.1399-0004.2002.610309.x"/>
</citation>
<scope>VARIANT BSTVS CYS-375</scope>
</reference>
<reference key="83">
<citation type="journal article" date="2005" name="J. Med. Genet." volume="42" first="656" last="662">
<title>Familial scaphocephaly syndrome caused by a novel mutation in the FGFR2 tyrosine kinase domain.</title>
<authorList>
<person name="McGillivray G."/>
<person name="Savarirayan R."/>
<person name="Cox T.C."/>
<person name="Stojkoski C."/>
<person name="McNeil R."/>
<person name="Bankier A."/>
<person name="Bateman J.F."/>
<person name="Roscioli T."/>
<person name="Gardner R.J.M."/>
<person name="Lamande S.R."/>
</authorList>
<dbReference type="PubMed" id="16061565"/>
<dbReference type="DOI" id="10.1136/jmg.2004.027888"/>
</citation>
<scope>VARIANT FSPC GLU-526</scope>
</reference>
<reference key="84">
<citation type="journal article" date="2006" name="Nat. Genet." volume="38" first="414" last="417">
<title>Mutations in different components of FGF signaling in LADD syndrome.</title>
<authorList>
<person name="Rohmann E."/>
<person name="Brunner H.G."/>
<person name="Kayserili H."/>
<person name="Uyguner O."/>
<person name="Nuernberg G."/>
<person name="Lew E.D."/>
<person name="Dobbie A."/>
<person name="Eswarakumar V.P."/>
<person name="Uzumcu A."/>
<person name="Ulubil-Emeroglu M."/>
<person name="Leroy J.G."/>
<person name="Li Y."/>
<person name="Becker C."/>
<person name="Lehnerdt K."/>
<person name="Cremers C.W.R.J."/>
<person name="Yueksel-Apak M."/>
<person name="Nuernberg P."/>
<person name="Kubisch C."/>
<person name="Schlessinger J."/>
<person name="van Bokhoven H."/>
<person name="Wollnik B."/>
</authorList>
<dbReference type="PubMed" id="16501574"/>
<dbReference type="DOI" id="10.1038/ng1757"/>
</citation>
<scope>VARIANTS LADDS THR-628; THR-648 AND 649-ARG-ASP-650 DELINS SER</scope>
</reference>
<reference key="85">
<citation type="journal article" date="2006" name="Science" volume="314" first="268" last="274">
<title>The consensus coding sequences of human breast and colorectal cancers.</title>
<authorList>
<person name="Sjoeblom T."/>
<person name="Jones S."/>
<person name="Wood L.D."/>
<person name="Parsons D.W."/>
<person name="Lin J."/>
<person name="Barber T.D."/>
<person name="Mandelker D."/>
<person name="Leary R.J."/>
<person name="Ptak J."/>
<person name="Silliman N."/>
<person name="Szabo S."/>
<person name="Buckhaults P."/>
<person name="Farrell C."/>
<person name="Meeh P."/>
<person name="Markowitz S.D."/>
<person name="Willis J."/>
<person name="Dawson D."/>
<person name="Willson J.K.V."/>
<person name="Gazdar A.F."/>
<person name="Hartigan J."/>
<person name="Wu L."/>
<person name="Liu C."/>
<person name="Parmigiani G."/>
<person name="Park B.H."/>
<person name="Bachman K.E."/>
<person name="Papadopoulos N."/>
<person name="Vogelstein B."/>
<person name="Kinzler K.W."/>
<person name="Velculescu V.E."/>
</authorList>
<dbReference type="PubMed" id="16959974"/>
<dbReference type="DOI" id="10.1126/science.1133427"/>
</citation>
<scope>VARIANT [LARGE SCALE ANALYSIS] CYS-203</scope>
</reference>
<reference key="86">
<citation type="journal article" date="2007" name="Nature" volume="446" first="153" last="158">
<title>Patterns of somatic mutation in human cancer genomes.</title>
<authorList>
<person name="Greenman C."/>
<person name="Stephens P."/>
<person name="Smith R."/>
<person name="Dalgliesh G.L."/>
<person name="Hunter C."/>
<person name="Bignell G."/>
<person name="Davies H."/>
<person name="Teague J."/>
<person name="Butler A."/>
<person name="Stevens C."/>
<person name="Edkins S."/>
<person name="O'Meara S."/>
<person name="Vastrik I."/>
<person name="Schmidt E.E."/>
<person name="Avis T."/>
<person name="Barthorpe S."/>
<person name="Bhamra G."/>
<person name="Buck G."/>
<person name="Choudhury B."/>
<person name="Clements J."/>
<person name="Cole J."/>
<person name="Dicks E."/>
<person name="Forbes S."/>
<person name="Gray K."/>
<person name="Halliday K."/>
<person name="Harrison R."/>
<person name="Hills K."/>
<person name="Hinton J."/>
<person name="Jenkinson A."/>
<person name="Jones D."/>
<person name="Menzies A."/>
<person name="Mironenko T."/>
<person name="Perry J."/>
<person name="Raine K."/>
<person name="Richardson D."/>
<person name="Shepherd R."/>
<person name="Small A."/>
<person name="Tofts C."/>
<person name="Varian J."/>
<person name="Webb T."/>
<person name="West S."/>
<person name="Widaa S."/>
<person name="Yates A."/>
<person name="Cahill D.P."/>
<person name="Louis D.N."/>
<person name="Goldstraw P."/>
<person name="Nicholson A.G."/>
<person name="Brasseur F."/>
<person name="Looijenga L."/>
<person name="Weber B.L."/>
<person name="Chiew Y.-E."/>
<person name="DeFazio A."/>
<person name="Greaves M.F."/>
<person name="Green A.R."/>
<person name="Campbell P."/>
<person name="Birney E."/>
<person name="Easton D.F."/>
<person name="Chenevix-Trench G."/>
<person name="Tan M.-H."/>
<person name="Khoo S.K."/>
<person name="Teh B.T."/>
<person name="Yuen S.T."/>
<person name="Leung S.Y."/>
<person name="Wooster R."/>
<person name="Futreal P.A."/>
<person name="Stratton M.R."/>
</authorList>
<dbReference type="PubMed" id="17344846"/>
<dbReference type="DOI" id="10.1038/nature05610"/>
</citation>
<scope>VARIANTS [LARGE SCALE ANALYSIS] LEU-57; THR-186; CYS-203; VAL-272; ASN-283; CYS-290 AND THR-612</scope>
</reference>
<reference key="87">
<citation type="journal article" date="2012" name="Am. J. Hum. Genet." volume="90" first="550" last="557">
<title>Bent bone dysplasia-FGFR2 type, a distinct skeletal disorder, has deficient canonical FGF signaling.</title>
<authorList>
<person name="Merrill A.E."/>
<person name="Sarukhanov A."/>
<person name="Krejci P."/>
<person name="Idoni B."/>
<person name="Camacho N."/>
<person name="Estrada K.D."/>
<person name="Lyons K.M."/>
<person name="Deixler H."/>
<person name="Robinson H."/>
<person name="Chitayat D."/>
<person name="Curry C.J."/>
<person name="Lachman R.S."/>
<person name="Wilcox W.R."/>
<person name="Krakow D."/>
</authorList>
<dbReference type="PubMed" id="22387015"/>
<dbReference type="DOI" id="10.1016/j.ajhg.2012.02.005"/>
</citation>
<scope>VARIANTS BBDS ASP-381 AND ARG-391</scope>
<scope>CHARACTERIZATION OF VARIANT BBDS ARG-391</scope>
</reference>
<reference key="88">
<citation type="journal article" date="2015" name="J. Med. Genet." volume="52" first="840" last="847">
<title>A human laterality disorder caused by a homozygous deleterious mutation in MMP21.</title>
<authorList>
<person name="Perles Z."/>
<person name="Moon S."/>
<person name="Ta-Shma A."/>
<person name="Yaacov B."/>
<person name="Francescatto L."/>
<person name="Edvardson S."/>
<person name="Rein A.J."/>
<person name="Elpeleg O."/>
<person name="Katsanis N."/>
</authorList>
<dbReference type="PubMed" id="26429889"/>
<dbReference type="DOI" id="10.1136/jmedgenet-2015-103336"/>
</citation>
<scope>VARIANT LEU-57</scope>
</reference>
<comment type="function">
<text evidence="37 41 42 44 46 49 51 54 56 57 58 60 73">Tyrosine-protein kinase that acts as cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of cell proliferation, differentiation, migration and apoptosis, and in the regulation of embryonic development. Required for normal embryonic patterning, trophoblast function, limb bud development, lung morphogenesis, osteogenesis and skin development. Plays an essential role in the regulation of osteoblast differentiation, proliferation and apoptosis, and is required for normal skeleton development. Promotes cell proliferation in keratinocytes and immature osteoblasts, but promotes apoptosis in differentiated osteoblasts. Phosphorylates PLCG1, FRS2 and PAK4. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. FGFR2 signaling is down-regulated by ubiquitination, internalization and degradation. Mutations that lead to constitutive kinase activation or impair normal FGFR2 maturation, internalization and degradation lead to aberrant signaling. Over-expressed FGFR2 promotes activation of STAT1.</text>
</comment>
<comment type="catalytic activity">
<text evidence="22 47 53 58 59">ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate.</text>
</comment>
<comment type="enzyme regulation">
<text evidence="52 59">Present in an inactive conformation in the absence of bound ligand. Ligand binding leads to dimerization and activation by autophosphorylation on tyrosine residues. Inhibited by ARQ 523 and ARQ 069; these compounds maintain the kinase in an inactive conformation and inhibit autophosphorylation.</text>
</comment>
<comment type="subunit">
<text evidence="18 25 28 31 34 37 38 39 40 41 42 44 46 47 51 52 53 55 56 59 73 77">Monomer. Homodimer after ligand binding. Interacts predominantly with FGF1 and FGF2, but can also interact with FGF3, FGF4, FGF6, FGF7, FGF8, FGF9, FGF10, FGF17, FGF18 and FGF22 (in vitro). Ligand specificity is determined by tissue-specific expression of isoforms, and differences in the third Ig-like domain are crucial for ligand specificity. Isoform 1 has high affinity for FGF1 and FGF2, but low affinity for FGF7. Isoform 3 has high affinity for FGF1 and FGF7, and has much higher affinity for FGF7 than isoform 1 (in vitro). Affinity for fibroblast growth factors (FGFs) is increased by heparan sulfate glycosaminoglycans that function as coreceptors. Likewise, KLB increases the affinity for FGF19 and FGF21. Interacts with PLCG1, GRB2 and PAK4. Interacts with FLRT2 (By similarity).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1028658"/>
<interactant intactId="EBI-6358090">
<id>P03968</id>
<label>FGF1</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1028658"/>
<interactant intactId="EBI-698068">
<id>P05230</id>
<label>FGF1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1028658"/>
<interactant intactId="EBI-1035684">
<id>O15520</id>
<label>FGF10</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1028658"/>
<interactant intactId="EBI-977447">
<id>P09038</id>
<label>FGF2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1028658"/>
<interactant intactId="EBI-11122080">
<id>P09038-2</id>
<label>FGF2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-6354683"/>
<interactant intactId="EBI-3937699">
<id>P21781</id>
<label>FGF7</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1028658"/>
<interactant intactId="EBI-401755">
<id>P62993</id>
<label>GRB2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Cell membrane</location>
<topology>Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location>Golgi apparatus</location>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasmic vesicle</location>
</subcellularLocation>
<text>Detected on osteoblast plasma membrane lipid rafts. After ligand binding, the activated receptor is rapidly internalized and degraded.</text>
</comment>
<comment type="subcellular location">
<molecule>Isoform 1</molecule>
<subcellularLocation>
<location>Cell membrane</location>
<topology>Single-pass type I membrane protein</topology>
</subcellularLocation>
<text>After ligand binding, the activated receptor is rapidly internalized and degraded.</text>
</comment>
<comment type="subcellular location">
<molecule>Isoform 3</molecule>
<subcellularLocation>
<location>Cell membrane</location>
<topology>Single-pass type I membrane protein</topology>
</subcellularLocation>
<text>After ligand binding, the activated receptor is rapidly internalized and degraded.</text>
</comment>
<comment type="subcellular location">
<molecule>Isoform 14</molecule>
<subcellularLocation>
<location>Secreted</location>
</subcellularLocation>
</comment>
<comment type="subcellular location">
<molecule>Isoform 19</molecule>
<subcellularLocation>
<location>Secreted</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P21802-1</id>
<name>1</name>
<name>BEK</name>
<name>FGFR2IIIc</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P21802-2</id>
<name>2</name>
<name>Short</name>
<sequence type="described" ref="VSP_002978"/>
</isoform>
<isoform>
<id>P21802-3</id>
<name>3</name>
<name>BFR-1</name>
<name>FGFR2IIIb</name>
<name>KGFR</name>
<sequence type="described" ref="VSP_002969 VSP_002970 VSP_002971 VSP_002972"/>
</isoform>
<isoform>
<id>P21802-4</id>
<name>4</name>
<name>K-sam</name>
<sequence type="described" ref="VSP_002964 VSP_002969 VSP_002970 VSP_002971 VSP_002972 VSP_002975 VSP_002976"/>
</isoform>
<isoform>
<id>P21802-5</id>
<name>5</name>
<name>K-sam-I</name>
<name>BEK</name>
<name>IgIIIc</name>
<sequence type="described" ref="VSP_002975"/>
</isoform>
<isoform>
<id>P21802-6</id>
<name>6</name>
<name>K-sam-IIC2</name>
<sequence type="described" ref="VSP_002975 VSP_002984"/>
</isoform>
<isoform>
<id>P21802-7</id>
<name>7</name>
<name>K-sam-IIO2</name>
<sequence type="described" ref="VSP_002969 VSP_002970 VSP_002971 VSP_002972 VSP_002979"/>
</isoform>
<isoform>
<id>P21802-8</id>
<name>8</name>
<name>K-sam-IIC3</name>
<sequence type="described" ref="VSP_002975 VSP_002978"/>
</isoform>
<isoform>
<id>P21802-9</id>
<name>9</name>
<name>K-sam-IIH1</name>
<sequence type="described" ref="VSP_002969 VSP_002970 VSP_002971 VSP_002972 VSP_002980"/>
</isoform>
<isoform>
<id>P21802-10</id>
<name>10</name>
<name>K-sam-IIH2</name>
<sequence type="described" ref="VSP_002969 VSP_002970 VSP_002971 VSP_002972 VSP_002981"/>
</isoform>
<isoform>
<id>P21802-11</id>
<name>11</name>
<name>K-sam-IIH3</name>
<name>K-sam-IIO4</name>
<sequence type="described" ref="VSP_002969 VSP_002970 VSP_002971 VSP_002972 VSP_002982"/>
</isoform>
<isoform>
<id>P21802-12</id>
<name>12</name>
<name>K-sam-IIO1</name>
<sequence type="described" ref="VSP_002969 VSP_002970 VSP_002971 VSP_002972 VSP_002983"/>
</isoform>
<isoform>
<id>P21802-13</id>
<name>13</name>
<name>K-sam-IIO3</name>
<sequence type="described" ref="VSP_002969 VSP_002970 VSP_002971 VSP_002972 VSP_002977"/>
</isoform>
<isoform>
<id>P21802-14</id>
<name>14</name>
<name>K-sam-IV</name>
<name>Soluble KGFR</name>
<sequence type="described" ref="VSP_002965 VSP_002966"/>
</isoform>
<isoform>
<id>P21802-15</id>
<name>15</name>
<name>K-sam-III</name>
<sequence type="described" ref="VSP_002968"/>
</isoform>
<isoform>
<id>P21802-16</id>
<name>16</name>
<name>TK14</name>
<sequence type="described" ref="VSP_002967 VSP_002975"/>
<text evidence="101">Ref.2 (AAA61188) sequence is in conflict in position: 315:T->L.</text>
</isoform>
<isoform>
<id>P21802-17</id>
<name>17</name>
<sequence type="described" ref="VSP_002969 VSP_002970 VSP_002971 VSP_002972 VSP_002978"/>
</isoform>
<isoform>
<id>P21802-18</id>
<name>18</name>
<name>K-sam-IIC1</name>
<name>KGFR</name>
<name>IgIIIb</name>
<sequence type="described" ref="VSP_002969 VSP_002970 VSP_002971 VSP_002972 VSP_002975"/>
</isoform>
<isoform>
<id>P21802-19</id>
<name>19</name>
<name>Soluble KGFR</name>
<sequence type="described" ref="VSP_002969 VSP_002970 VSP_002971 VSP_002972 VSP_002973 VSP_002974"/>
</isoform>
<isoform>
<id>P21802-20</id>
<name>20</name>
<sequence type="described" ref="VSP_019608 VSP_019609"/>
</isoform>
<isoform>
<id>P21802-21</id>
<name>21</name>
<sequence type="described" ref="VSP_002964 VSP_041915"/>
</isoform>
<isoform>
<id>P21802-22</id>
<name>22</name>
<sequence type="described" ref="VSP_002964 VSP_002969 VSP_002970 VSP_002971 VSP_002972 VSP_002978"/>
</isoform>
<isoform>
<id>P21802-23</id>
<name>23</name>
<sequence type="described" ref="VSP_041914"/>
</isoform>
</comment>
<comment type="domain">
<text evidence="39 40 77">The second and third Ig-like domains directly interact with fibroblast growth factors (FGF) and heparan sulfate proteoglycans. Alternative splicing events affecting the third Ig-like domain are crucial for ligand selectivity.</text>
</comment>
<comment type="PTM">
<text evidence="42 55">Autophosphorylated. Binding of FGF family members together with heparan sulfate proteoglycan or heparin promotes receptor dimerization and autophosphorylation on several tyrosine residues. Autophosphorylation occurs in trans between the two FGFR molecules present in the dimer. Phosphorylation at Tyr-769 is essential for interaction with PLCG1.</text>
</comment>
<comment type="PTM">
<text evidence="47 49">N-glycosylated in the endoplasmic reticulum. The N-glycan chains undergo further maturation to an Endo H-resistant form in the Golgi apparatus.</text>
</comment>
<comment type="PTM">
<text evidence="41 47 60">Ubiquitinated. FGFR2 is rapidly ubiquitinated after autophosphorylation, leading to internalization and degradation. Subject to degradation both in lysosomes and by the proteasome.</text>
</comment>
<comment type="disease" evidence="24 32 33 35 52 63 64 69 70 71 72 75 76 78 80 83 85 88">
<disease id="DI-00383">
<name>Crouzon syndrome</name>
<acronym>CS</acronym>
<description>An autosomal dominant syndrome characterized by craniosynostosis, hypertelorism, exophthalmos and external strabismus, parrot-beaked nose, short upper lip, hypoplastic maxilla, and a relative mandibular prognathism.</description>
<dbReference type="MIM" id="123500"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="69 71 72 81 85">
<disease id="DI-00602">
<name>Jackson-Weiss syndrome</name>
<acronym>JWS</acronym>
<description>An autosomal dominant craniosynostosis syndrome characterized by craniofacial abnormalities and abnormality of the feet: broad great toes with medial deviation and tarsal-metatarsal coalescence.</description>
<dbReference type="MIM" id="123150"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="34 35 41 65 67 78 82 85">
<disease id="DI-00131">
<name>Apert syndrome</name>
<acronym>APRS</acronym>
<description>A syndrome characterized by facio-cranio-synostosis, osseous and membranous syndactyly of the four extremities, and midface hypoplasia. The craniosynostosis is bicoronal and results in acrocephaly of brachysphenocephalic type. Syndactyly of the fingers and toes may be total (mitten hands and sock feet) or partial affecting the second, third, and fourth digits. Intellectual deficit is frequent and often severe, usually being associated with cerebral malformations.</description>
<dbReference type="MIM" id="101200"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="23 29 32 35 47 52 66 68 72 78 79 86 87">
<disease id="DI-00924">
<name>Pfeiffer syndrome</name>
<acronym>PS</acronym>
<description>A syndrome characterized by the association of craniosynostosis, broad and deviated thumbs and big toes, and partial syndactyly of the fingers and toes. Three subtypes are known: mild autosomal dominant form (type 1); cloverleaf skull, elbow ankylosis, early death, sporadic (type 2); craniosynostosis, early demise, sporadic (type 3).</description>
<dbReference type="MIM" id="101600"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="36 74">
<disease id="DI-01270">
<name>Beare-Stevenson cutis gyrata syndrome</name>
<acronym>BSTVS</acronym>
<description>An autosomal dominant disease characterized by craniofacial anomalies, particularly craniosynostosis, and ear defects, cutis gyrata, acanthosis nigricans, anogenital anomalies, skin tags, and prominent umbilical stump. The skin furrows have a corrugated appearance and are widespread. Cutis gyrata variably affects the scalp, forehead, face, preauricular area, neck, trunk, hands, and feet.</description>
<dbReference type="MIM" id="123790"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="43 52">
<disease id="DI-00498">
<name>Familial scaphocephaly syndrome</name>
<acronym>FSPC</acronym>
<description>An autosomal dominant craniosynostosis syndrome characterized by scaphocephaly, macrocephaly, hypertelorism, maxillary retrusion, and mild intellectual disability. Scaphocephaly is the most common of the craniosynostosis conditions and is characterized by a long, narrow head. It is due to premature fusion of the sagittal suture or from external deformation.</description>
<dbReference type="MIM" id="609579"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="45 53">
<disease id="DI-00627">
<name>Lacrimo-auriculo-dento-digital syndrome</name>
<acronym>LADDS</acronym>
<description>An autosomal dominant ectodermal dysplasia, a heterogeneous group of disorders due to abnormal development of two or more ectodermal structures. Lacrimo-auriculo-dento-digital syndrome is characterized by aplastic/hypoplastic lacrimal and salivary glands and ducts, cup-shaped ears, hearing loss, hypodontia and enamel hypoplasia, and distal limb segments anomalies. In addition to these cardinal features, facial dysmorphism, malformations of the kidney and respiratory system and abnormal genitalia have been reported. Craniosynostosis and severe syndactyly are not observed.</description>
<dbReference type="MIM" id="149730"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="27">
<disease id="DI-00125">
<name>Antley-Bixler syndrome, without genital anomalies or disordered steroidogenesis</name>
<acronym>ABS2</acronym>
<description>A rare syndrome characterized by craniosynostosis, radiohumeral synostosis present from the perinatal period, midface hypoplasia, choanal stenosis or atresia, femoral bowing and multiple joint contractures. Arachnodactyly and/or camptodactyly have also been reported.</description>
<dbReference type="MIM" id="207410"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="61">
<disease id="DI-03429">
<name>Bent bone dysplasia syndrome</name>
<acronym>BBDS</acronym>
<description>A perinatal lethal skeletal dysplasia characterized by poor mineralization of the calvarium, craniosynostosis, dysmorphic facial features, prenatal teeth, hypoplastic pubis and clavicles, osteopenia, and bent long bones. Dysmorphic facial features included low-set ears, hypertelorism, midface hypoplasia, prematurely erupted fetal teeth, and micrognathia.</description>
<dbReference type="MIM" id="614592"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="84">
<disease id="DI-01006">
<name>Saethre-Chotzen syndrome</name>
<acronym>SCS</acronym>
<description>A craniosynostosis syndrome characterized by coronal synostosis, brachycephaly, low frontal hairline, facial asymmetry, hypertelorism, broad halluces, and clinodactyly.</description>
<dbReference type="MIM" id="101400"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="21">Belongs to the protein kinase superfamily. Tyr protein kinase family. Fibroblast growth factor receptor subfamily.</text>
</comment>
<comment type="sequence caution" evidence="101">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="BAG57383" version="1"/>
</conflict>
<text>Translation N-terminally shortened.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/FGFR2ID40570ch10q26.html"/>
</comment>
<comment type="online information" name="NIEHS-SNPs">
<link uri="http://egp.gs.washington.edu/data/fgfr2/"/>
</comment>
<dbReference type="EC" id="2.7.10.1" evidence="47 53 58 59"/>
<dbReference type="EMBL" id="X52832">
<property type="protein sequence ID" value="CAA37014.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M55614">
<property type="protein sequence ID" value="AAA61188.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X56191">
<property type="protein sequence ID" value="CAA39654.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M35718">
<property type="protein sequence ID" value="AAA36152.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M87770">
<property type="protein sequence ID" value="AAA59470.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M87771">
<property type="protein sequence ID" value="AAA59471.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M87772">
<property type="protein sequence ID" value="AAA59472.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M97193">
<property type="protein sequence ID" value="AAA52449.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U11814">
<property type="protein sequence ID" value="AAA68514.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M80634">
<property type="protein sequence ID" value="AAA36147.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="Z71929">
<property type="protein sequence ID" value="CAA96492.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB030073">
<property type="protein sequence ID" value="BAA89296.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB030074">
<property type="protein sequence ID" value="BAA89297.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB030075">
<property type="protein sequence ID" value="BAA89298.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB030076">
<property type="protein sequence ID" value="BAA89299.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB030077">
<property type="protein sequence ID" value="BAA89300.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB030078">
<property type="protein sequence ID" value="BAA89301.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF360695">
<property type="protein sequence ID" value="AAK94205.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF410480">
<property type="protein sequence ID" value="AAK94205.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF360695">
<property type="protein sequence ID" value="AAK94206.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF410480">
<property type="protein sequence ID" value="AAK94206.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF360695">
<property type="protein sequence ID" value="AAK94207.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF410480">
<property type="protein sequence ID" value="AAK94207.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF360695">
<property type="protein sequence ID" value="AAK94208.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF410480">
<property type="protein sequence ID" value="AAK94208.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF360695">
<property type="protein sequence ID" value="AAK94209.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF410480">
<property type="protein sequence ID" value="AAK94209.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF487553">
<property type="protein sequence ID" value="AAM74056.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AB084153">
<property type="protein sequence ID" value="BAC45037.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ493927">
<property type="protein sequence ID" value="ABE96832.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AK294026">
<property type="protein sequence ID" value="BAG57383.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC009988">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC039243">
<property type="protein sequence ID" value="AAH39243.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF169399">
<property type="protein sequence ID" value="AAF43273.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF169399">
<property type="protein sequence ID" value="AAF43274.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF097353">
<property type="protein sequence ID" value="AAD31560.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF097341">
<property type="protein sequence ID" value="AAD31560.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF097342">
<property type="protein sequence ID" value="AAD31560.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF097343">
<property type="protein sequence ID" value="AAD31560.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF097345">
<property type="protein sequence ID" value="AAD31560.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF097346">
<property type="protein sequence ID" value="AAD31560.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF097347">
<property type="protein sequence ID" value="AAD31560.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF097348">
<property type="protein sequence ID" value="AAD31560.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF097349">
<property type="protein sequence ID" value="AAD31560.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF097350">
<property type="protein sequence ID" value="AAD31560.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF097351">
<property type="protein sequence ID" value="AAD31560.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF097352">
<property type="protein sequence ID" value="AAD31560.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF097353">
<property type="protein sequence ID" value="AAD31561.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF097341">
<property type="protein sequence ID" value="AAD31561.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF097342">
<property type="protein sequence ID" value="AAD31561.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF097344">
<property type="protein sequence ID" value="AAD31561.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF097345">
<property type="protein sequence ID" value="AAD31561.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF097346">
<property type="protein sequence ID" value="AAD31561.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF097347">
<property type="protein sequence ID" value="AAD31561.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF097348">
<property type="protein sequence ID" value="AAD31561.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF097349">
<property type="protein sequence ID" value="AAD31561.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF097350">
<property type="protein sequence ID" value="AAD31561.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF097351">
<property type="protein sequence ID" value="AAD31561.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF097352">
<property type="protein sequence ID" value="AAD31561.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF097340">
<property type="protein sequence ID" value="AAD31562.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF097337">
<property type="protein sequence ID" value="AAD31562.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF097338">
<property type="protein sequence ID" value="AAD31562.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF097339">
<property type="protein sequence ID" value="AAD31562.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF097354">
<property type="protein sequence ID" value="AAD31565.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF097341">
<property type="protein sequence ID" value="AAD31567.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="S82438">
<property type="protein sequence ID" value="AAD14392.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Y17131">
<property type="protein sequence ID" value="CAA76643.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L49237">
<property type="protein sequence ID" value="AAC41933.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L49242">
<property type="protein sequence ID" value="AAC41934.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L49238">
<property type="protein sequence ID" value="AAC41935.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L49239">
<property type="protein sequence ID" value="AAC41936.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L49240">
<property type="protein sequence ID" value="AAC41937.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L49241">
<property type="protein sequence ID" value="AAC41938.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS31298.1">
<molecule id="P21802-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS44485.1">
<molecule id="P21802-20"/>
</dbReference>
<dbReference type="CCDS" id="CCDS44486.1">
<molecule id="P21802-23"/>
</dbReference>
<dbReference type="CCDS" id="CCDS44487.1">
<molecule id="P21802-15"/>
</dbReference>
<dbReference type="CCDS" id="CCDS44488.1">
<molecule id="P21802-22"/>
</dbReference>
<dbReference type="CCDS" id="CCDS44489.1">
<molecule id="P21802-17"/>
</dbReference>
<dbReference type="CCDS" id="CCDS53584.1">
<molecule id="P21802-21"/>
</dbReference>
<dbReference type="CCDS" id="CCDS7620.2">
<molecule id="P21802-3"/>
</dbReference>
<dbReference type="CCDS" id="CCDS81515.1">
<molecule id="P21802-5"/>
</dbReference>
<dbReference type="PIR" id="A35969">
<property type="entry name" value="A35969"/>
</dbReference>
<dbReference type="PIR" id="A42691">
<property type="entry name" value="TVHUF2"/>
</dbReference>
<dbReference type="PIR" id="A45081">
<property type="entry name" value="A45081"/>
</dbReference>
<dbReference type="PIR" id="C42691">
<property type="entry name" value="C42691"/>
</dbReference>
<dbReference type="PIR" id="S16236">
<property type="entry name" value="S16236"/>
</dbReference>
<dbReference type="RefSeq" id="NP_000132.3">
<molecule id="P21802-1"/>
<property type="nucleotide sequence ID" value="NM_000141.4"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001138385.1">
<molecule id="P21802-17"/>
<property type="nucleotide sequence ID" value="NM_001144913.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001138386.1">
<molecule id="P21802-23"/>
<property type="nucleotide sequence ID" value="NM_001144914.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001138387.1">
<molecule id="P21802-21"/>
<property type="nucleotide sequence ID" value="NM_001144915.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001138388.1">
<property type="nucleotide sequence ID" value="NM_001144916.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001138389.1">
<molecule id="P21802-15"/>
<property type="nucleotide sequence ID" value="NM_001144917.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001138390.1">
<molecule id="P21802-20"/>
<property type="nucleotide sequence ID" value="NM_001144918.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001138391.1">
<molecule id="P21802-22"/>
<property type="nucleotide sequence ID" value="NM_001144919.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001307583.1">
<property type="nucleotide sequence ID" value="NM_001320654.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001307587.1">
<molecule id="P21802-5"/>
<property type="nucleotide sequence ID" value="NM_001320658.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_075259.4">
<molecule id="P21802-3"/>
<property type="nucleotide sequence ID" value="NM_022970.3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_075418.1">
<property type="nucleotide sequence ID" value="NM_023029.2"/>
</dbReference>
<dbReference type="UniGene" id="Hs.533683"/>
<dbReference type="PDB" id="1DJS">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A=32-362"/>
</dbReference>
<dbReference type="PDB" id="1E0O">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="B/D=148-366"/>
</dbReference>
<dbReference type="PDB" id="1EV2">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="E/F/G/H=147-366"/>
</dbReference>
<dbReference type="PDB" id="1GJO">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A=456-768"/>
</dbReference>
<dbReference type="PDB" id="1II4">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="E/F/G/H=147-366"/>
</dbReference>
<dbReference type="PDB" id="1IIL">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="E/F/G/H=147-366"/>
</dbReference>
<dbReference type="PDB" id="1NUN">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="B=140-368"/>
</dbReference>
<dbReference type="PDB" id="1OEC">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A=456-768"/>
</dbReference>
<dbReference type="PDB" id="1WVZ">
<property type="method" value="NMR"/>
<property type="chains" value="A=147-249"/>
</dbReference>
<dbReference type="PDB" id="2FDB">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.28"/>
<property type="chains" value="P/R=149-368"/>
</dbReference>
<dbReference type="PDB" id="2PSQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A/B=413-768"/>
</dbReference>
<dbReference type="PDB" id="2PVF">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A=458-778, B=764-778"/>
</dbReference>
<dbReference type="PDB" id="2PVY">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A/B/C/D=458-768"/>
</dbReference>
<dbReference type="PDB" id="2PWL">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A/B=458-768"/>
</dbReference>
<dbReference type="PDB" id="2PY3">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A/B=458-768"/>
</dbReference>
<dbReference type="PDB" id="2PZ5">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A/B=458-768"/>
</dbReference>
<dbReference type="PDB" id="2PZP">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A/B=458-768"/>
</dbReference>
<dbReference type="PDB" id="2PZR">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A/B=458-768"/>
</dbReference>
<dbReference type="PDB" id="2Q0B">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="A/B=458-768"/>
</dbReference>
<dbReference type="PDB" id="3B2T">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A/B=458-766"/>
</dbReference>
<dbReference type="PDB" id="3CAF">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.96"/>
<property type="chains" value="A=150-249"/>
</dbReference>
<dbReference type="PDB" id="3CLY">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=458-778"/>
</dbReference>
<dbReference type="PDB" id="3CU1">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A/C=150-249"/>
</dbReference>
<dbReference type="PDB" id="3DAR">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A/B=146-249"/>
</dbReference>
<dbReference type="PDB" id="3EUU">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.34"/>
<property type="chains" value="A/B=150-249"/>
</dbReference>
<dbReference type="PDB" id="3OJ2">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="C/D=140-313"/>
</dbReference>
<dbReference type="PDB" id="3OJM">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="B=140-313"/>
</dbReference>
<dbReference type="PDB" id="3RI1">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A/B=458-768"/>
</dbReference>
<dbReference type="PDB" id="4J23">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.88"/>
<property type="chains" value="A=147-366"/>
</dbReference>
<dbReference type="PDB" id="4J95">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.38"/>
<property type="chains" value="A/B/C/D=458-768"/>
</dbReference>
<dbReference type="PDB" id="4J96">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A/B=458-768"/>
</dbReference>
<dbReference type="PDB" id="4J97">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.55"/>
<property type="chains" value="A/B/C/D=458-768"/>
</dbReference>
<dbReference type="PDB" id="4J98">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.31"/>
<property type="chains" value="A/B=458-768"/>
</dbReference>
<dbReference type="PDB" id="4J99">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.85"/>
<property type="chains" value="A/B/C/D=458-768"/>
</dbReference>
<dbReference type="PDB" id="4WV1">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.36"/>
<property type="chains" value="C/F=153-251"/>
</dbReference>
<dbReference type="PDB" id="5EG3">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.61"/>
<property type="chains" value="A=458-778"/>
</dbReference>
<dbReference type="PDB" id="5UGL">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.86"/>
<property type="chains" value="A/B=458-768"/>
</dbReference>
<dbReference type="PDB" id="5UGX">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.35"/>
<property type="chains" value="A/B=458-768"/>
</dbReference>
<dbReference type="PDB" id="5UHN">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.91"/>
<property type="chains" value="A/B=458-768"/>
</dbReference>
<dbReference type="PDB" id="5UI0">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.05"/>
<property type="chains" value="A/B=458-768"/>
</dbReference>
<dbReference type="PDBsum" id="1DJS"/>
<dbReference type="PDBsum" id="1E0O"/>
<dbReference type="PDBsum" id="1EV2"/>
<dbReference type="PDBsum" id="1GJO"/>
<dbReference type="PDBsum" id="1II4"/>
<dbReference type="PDBsum" id="1IIL"/>
<dbReference type="PDBsum" id="1NUN"/>
<dbReference type="PDBsum" id="1OEC"/>
<dbReference type="PDBsum" id="1WVZ"/>
<dbReference type="PDBsum" id="2FDB"/>
<dbReference type="PDBsum" id="2PSQ"/>
<dbReference type="PDBsum" id="2PVF"/>
<dbReference type="PDBsum" id="2PVY"/>
<dbReference type="PDBsum" id="2PWL"/>
<dbReference type="PDBsum" id="2PY3"/>
<dbReference type="PDBsum" id="2PZ5"/>
<dbReference type="PDBsum" id="2PZP"/>
<dbReference type="PDBsum" id="2PZR"/>
<dbReference type="PDBsum" id="2Q0B"/>
<dbReference type="PDBsum" id="3B2T"/>
<dbReference type="PDBsum" id="3CAF"/>
<dbReference type="PDBsum" id="3CLY"/>
<dbReference type="PDBsum" id="3CU1"/>
<dbReference type="PDBsum" id="3DAR"/>
<dbReference type="PDBsum" id="3EUU"/>
<dbReference type="PDBsum" id="3OJ2"/>
<dbReference type="PDBsum" id="3OJM"/>
<dbReference type="PDBsum" id="3RI1"/>
<dbReference type="PDBsum" id="4J23"/>
<dbReference type="PDBsum" id="4J95"/>
<dbReference type="PDBsum" id="4J96"/>
<dbReference type="PDBsum" id="4J97"/>
<dbReference type="PDBsum" id="4J98"/>
<dbReference type="PDBsum" id="4J99"/>
<dbReference type="PDBsum" id="4WV1"/>
<dbReference type="PDBsum" id="5EG3"/>
<dbReference type="PDBsum" id="5UGL"/>
<dbReference type="PDBsum" id="5UGX"/>
<dbReference type="PDBsum" id="5UHN"/>
<dbReference type="PDBsum" id="5UI0"/>
<dbReference type="ProteinModelPortal" id="P21802"/>
<dbReference type="SMR" id="P21802"/>
<dbReference type="BioGrid" id="108554">
<property type="interactions" value="76"/>
</dbReference>
<dbReference type="DIP" id="DIP-3788N"/>
<dbReference type="IntAct" id="P21802">
<property type="interactions" value="28"/>
</dbReference>
<dbReference type="MINT" id="MINT-118359"/>
<dbReference type="STRING" id="9606.ENSP00000410294"/>
<dbReference type="BindingDB" id="P21802"/>
<dbReference type="ChEMBL" id="CHEMBL4142"/>
<dbReference type="DrugBank" id="DB02491">
<property type="generic name" value="4-[4-(1-Amino-1-Methylethyl)Phenyl]-5-Chloro-N-[4-(2-Morpholin-4-Ylethyl)Phenyl]Pyrimidin-2-Amine"/>
</dbReference>
<dbReference type="DrugBank" id="DB09078">
<property type="generic name" value="Lenvatinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB09079">
<property type="generic name" value="Nintedanib"/>
</dbReference>
<dbReference type="DrugBank" id="DB00039">
<property type="generic name" value="Palifermin"/>
</dbReference>
<dbReference type="DrugBank" id="DB08901">
<property type="generic name" value="Ponatinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB08896">
<property type="generic name" value="Regorafenib"/>
</dbReference>
<dbReference type="DrugBank" id="DB02058">
<property type="generic name" value="SU4984"/>
</dbReference>
<dbReference type="DrugBank" id="DB01041">
<property type="generic name" value="Thalidomide"/>
</dbReference>
<dbReference type="GuidetoPHARMACOLOGY" id="1809"/>
<dbReference type="iPTMnet" id="P21802"/>
<dbReference type="PhosphoSitePlus" id="P21802"/>
<dbReference type="BioMuta" id="FGFR2"/>
<dbReference type="DMDM" id="120049"/>
<dbReference type="PaxDb" id="P21802"/>
<dbReference type="PeptideAtlas" id="P21802"/>
<dbReference type="PRIDE" id="P21802"/>
<dbReference type="TopDownProteomics" id="P21802-8">
<molecule id="P21802-8"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000346997">
<molecule id="P21802-5"/>
<property type="protein sequence ID" value="ENSP00000263451"/>
<property type="gene ID" value="ENSG00000066468"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000356226">
<molecule id="P21802-20"/>
<property type="protein sequence ID" value="ENSP00000348559"/>
<property type="gene ID" value="ENSG00000066468"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000357555">
<molecule id="P21802-21"/>
<property type="protein sequence ID" value="ENSP00000350166"/>
<property type="gene ID" value="ENSG00000066468"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000358487">
<molecule id="P21802-1"/>
<property type="protein sequence ID" value="ENSP00000351276"/>
<property type="gene ID" value="ENSG00000066468"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000359354">
<molecule id="P21802-14"/>
<property type="protein sequence ID" value="ENSP00000352309"/>
<property type="gene ID" value="ENSG00000066468"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000360144">
<molecule id="P21802-22"/>
<property type="protein sequence ID" value="ENSP00000353262"/>
<property type="gene ID" value="ENSG00000066468"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000369056">
<molecule id="P21802-17"/>
<property type="protein sequence ID" value="ENSP00000358052"/>
<property type="gene ID" value="ENSG00000066468"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000369058">
<molecule id="P21802-13"/>
<property type="protein sequence ID" value="ENSP00000358054"/>
<property type="gene ID" value="ENSG00000066468"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000369060">
<molecule id="P21802-15"/>
<property type="protein sequence ID" value="ENSP00000358056"/>
<property type="gene ID" value="ENSG00000066468"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000369061">
<molecule id="P21802-23"/>
<property type="protein sequence ID" value="ENSP00000358057"/>
<property type="gene ID" value="ENSG00000066468"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000457416">
<molecule id="P21802-3"/>
<property type="protein sequence ID" value="ENSP00000410294"/>
<property type="gene ID" value="ENSG00000066468"/>
</dbReference>
<dbReference type="GeneID" id="2263"/>
<dbReference type="KEGG" id="hsa:2263"/>
<dbReference type="UCSC" id="uc010qtl.3">
<molecule id="P21802-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="2263"/>
<dbReference type="DisGeNET" id="2263"/>
<dbReference type="GeneCards" id="FGFR2"/>
<dbReference type="GeneReviews" id="FGFR2"/>
<dbReference type="HGNC" id="HGNC:3689">
<property type="gene designation" value="FGFR2"/>
</dbReference>
<dbReference type="HPA" id="CAB010886"/>
<dbReference type="HPA" id="HPA035305"/>
<dbReference type="HPA" id="HPA056562"/>
<dbReference type="MalaCards" id="FGFR2"/>
<dbReference type="MIM" id="101200">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="101400">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="101600">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="123150">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="123500">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="123790">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="149730">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="176943">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="207410">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="609579">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="614592">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P21802"/>
<dbReference type="OpenTargets" id="ENSG00000066468"/>
<dbReference type="Orphanet" id="83">
<property type="disease" value="Antley-Bixler syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="87">
<property type="disease" value="Apert syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="207">
<property type="disease" value="Crouzon disease"/>
</dbReference>
<dbReference type="Orphanet" id="1555">
<property type="disease" value="Cutis gyrata - acanthosis nigricans - craniosynostosis"/>
</dbReference>
<dbReference type="Orphanet" id="168624">
<property type="disease" value="Familial scaphocephaly syndrome, McGillivray type"/>
</dbReference>
<dbReference type="Orphanet" id="313855">
<property type="disease" value="FGFR2-related bent bone dysplasia"/>
</dbReference>
<dbReference type="Orphanet" id="1540">
<property type="disease" value="Jackson-Weiss syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="2363">
<property type="disease" value="Lacrimoauriculodentodigital syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="93258">
<property type="disease" value="Pfeiffer syndrome type 1"/>
</dbReference>
<dbReference type="Orphanet" id="93259">
<property type="disease" value="Pfeiffer syndrome type 2"/>
</dbReference>
<dbReference type="Orphanet" id="93260">
<property type="disease" value="Pfeiffer syndrome type 3"/>
</dbReference>
<dbReference type="Orphanet" id="794">
<property type="disease" value="Saethre-Chotzen syndrome"/>
</dbReference>
<dbReference type="PharmGKB" id="PA28128"/>
<dbReference type="eggNOG" id="KOG0200">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG0515">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00760000118923"/>
<dbReference type="HOGENOM" id="HOG000263410"/>
<dbReference type="HOVERGEN" id="HBG000345"/>
<dbReference type="InParanoid" id="P21802"/>
<dbReference type="KO" id="K05093"/>
<dbReference type="OrthoDB" id="EOG091G0CQZ"/>
<dbReference type="PhylomeDB" id="P21802"/>
<dbReference type="TreeFam" id="TF316307"/>
<dbReference type="BRENDA" id="2.7.10.1">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-109704">
<property type="pathway name" value="PI3K Cascade"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1257604">
<property type="pathway name" value="PIP3 activates AKT signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-190375">
<property type="pathway name" value="FGFR2c ligand binding and activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-190377">
<property type="pathway name" value="FGFR2b ligand binding and activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2023837">
<property type="pathway name" value="Signaling by FGFR2 amplification mutants"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2033519">
<property type="pathway name" value="Activated point mutants of FGFR2"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2219530">
<property type="pathway name" value="Constitutive Signaling by Aberrant PI3K in Cancer"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5654221">
<property type="pathway name" value="Phospholipase C-mediated cascade, FGFR2"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5654695">
<property type="pathway name" value="PI-3K cascade:FGFR2"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5654699">
<property type="pathway name" value="SHC-mediated cascade:FGFR2"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5654700">
<property type="pathway name" value="FRS-mediated FGFR2 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5654727">
<property type="pathway name" value="Negative regulation of FGFR2 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5655253">
<property type="pathway name" value="Signaling by FGFR2 in disease"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5673001">
<property type="pathway name" value="RAF/MAP kinase cascade"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6811558">
<property type="pathway name" value="PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8851708">
<property type="pathway name" value="Signaling by FGFR2 IIIa TM"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8853333">
<property type="pathway name" value="Signaling by FGFR2 fusions"/>
</dbReference>
<dbReference type="SignaLink" id="P21802"/>
<dbReference type="SIGNOR" id="P21802"/>
<dbReference type="ChiTaRS" id="FGFR2">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P21802"/>
<dbReference type="GeneWiki" id="Fibroblast_growth_factor_receptor_2"/>
<dbReference type="GenomeRNAi" id="2263"/>
<dbReference type="PRO" id="PR:P21802"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 10"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000066468"/>
<dbReference type="ExpressionAtlas" id="P21802">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P21802">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005938">
<property type="term" value="C:cell cortex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0009986">
<property type="term" value="C:cell surface"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031410">
<property type="term" value="C:cytoplasmic vesicle"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0060076">
<property type="term" value="C:excitatory synapse"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005576">
<property type="term" value="C:extracellular region"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005794">
<property type="term" value="C:Golgi apparatus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0016021">
<property type="term" value="C:integral component of membrane"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005887">
<property type="term" value="C:integral component of plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043231">
<property type="term" value="C:intracellular membrane-bounded organelle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0016020">
<property type="term" value="C:membrane"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0016303">
<property type="term" value="F:1-phosphatidylinositol-3-kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0017134">
<property type="term" value="F:fibroblast growth factor binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005007">
<property type="term" value="F:fibroblast growth factor-activated receptor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008201">
<property type="term" value="F:heparin binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0046934">
<property type="term" value="F:phosphatidylinositol-4,5-bisphosphate 3-kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0042803">
<property type="term" value="F:protein homodimerization activity"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004713">
<property type="term" value="F:protein tyrosine kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005088">
<property type="term" value="F:Ras guanyl-nucleotide exchange factor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0001525">
<property type="term" value="P:angiogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0009887">
<property type="term" value="P:animal organ morphogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006915">
<property type="term" value="P:apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0007409">
<property type="term" value="P:axonogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060348">
<property type="term" value="P:bone development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030282">
<property type="term" value="P:bone mineralization"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060349">
<property type="term" value="P:bone morphogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060667">
<property type="term" value="P:branch elongation involved in salivary gland morphogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060670">
<property type="term" value="P:branching involved in labyrinthine layer morphogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060442">
<property type="term" value="P:branching involved in prostate gland morphogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060445">
<property type="term" value="P:branching involved in salivary gland morphogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048755">
<property type="term" value="P:branching morphogenesis of a nerve"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060449">
<property type="term" value="P:bud elongation involved in lung branching"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045165">
<property type="term" value="P:cell fate commitment"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007267">
<property type="term" value="P:cell-cell signaling"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048565">
<property type="term" value="P:digestive tract development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048701">
<property type="term" value="P:embryonic cranial skeleton morphogenesis"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0048557">
<property type="term" value="P:embryonic digestive tract morphogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048568">
<property type="term" value="P:embryonic organ development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048562">
<property type="term" value="P:embryonic organ morphogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0009880">
<property type="term" value="P:embryonic pattern specification"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048730">
<property type="term" value="P:epidermis morphogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030855">
<property type="term" value="P:epithelial cell differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060664">
<property type="term" value="P:epithelial cell proliferation involved in salivary gland morphogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001837">
<property type="term" value="P:epithelial to mesenchymal transition"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0008543">
<property type="term" value="P:fibroblast growth factor receptor signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035603">
<property type="term" value="P:fibroblast growth factor receptor signaling pathway involved in hemopoiesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060595">
<property type="term" value="P:fibroblast growth factor receptor signaling pathway involved in mammary gland specification"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035602">
<property type="term" value="P:fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035607">
<property type="term" value="P:fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035604">
<property type="term" value="P:fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0022612">
<property type="term" value="P:gland morphogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031069">
<property type="term" value="P:hair follicle morphogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001701">
<property type="term" value="P:in utero embryonic development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042472">
<property type="term" value="P:inner ear morphogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032808">
<property type="term" value="P:lacrimal gland development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060601">
<property type="term" value="P:lateral sprouting from an epithelium"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060174">
<property type="term" value="P:limb bud formation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048286">
<property type="term" value="P:lung alveolus development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030324">
<property type="term" value="P:lung development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060463">
<property type="term" value="P:lung lobe morphogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060484">
<property type="term" value="P:lung-associated mesenchyme development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060615">
<property type="term" value="P:mammary gland bud formation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000165">
<property type="term" value="P:MAPK cascade"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0003149">
<property type="term" value="P:membranous septum morphogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048762">
<property type="term" value="P:mesenchymal cell differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060915">
<property type="term" value="P:mesenchymal cell differentiation involved in lung development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060916">
<property type="term" value="P:mesenchymal cell proliferation involved in lung development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048333">
<property type="term" value="P:mesodermal cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030901">
<property type="term" value="P:midbrain development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016331">
<property type="term" value="P:morphogenesis of embryonic epithelium"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035264">
<property type="term" value="P:multicellular organism growth"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050680">
<property type="term" value="P:negative regulation of epithelial cell proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0000122">
<property type="term" value="P:negative regulation of transcription from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042476">
<property type="term" value="P:odontogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0021769">
<property type="term" value="P:orbitofrontal cortex development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035265">
<property type="term" value="P:organ growth"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030916">
<property type="term" value="P:otic vesicle formation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003148">
<property type="term" value="P:outflow tract septum morphogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0018108">
<property type="term" value="P:peptidyl-tyrosine phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048015">
<property type="term" value="P:phosphatidylinositol-mediated signaling"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0090263">
<property type="term" value="P:positive regulation of canonical Wnt signaling pathway"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060045">
<property type="term" value="P:positive regulation of cardiac muscle cell proliferation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045787">
<property type="term" value="P:positive regulation of cell cycle"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051781">
<property type="term" value="P:positive regulation of cell division"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008284">
<property type="term" value="P:positive regulation of cell proliferation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050679">
<property type="term" value="P:positive regulation of epithelial cell proliferation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060501">
<property type="term" value="P:positive regulation of epithelial cell proliferation involved in lung morphogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070374">
<property type="term" value="P:positive regulation of ERK1 and ERK2 cascade"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043410">
<property type="term" value="P:positive regulation of MAPK cascade"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002053">
<property type="term" value="P:positive regulation of mesenchymal cell proliferation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010518">
<property type="term" value="P:positive regulation of phospholipase activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048661">
<property type="term" value="P:positive regulation of smooth muscle cell proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030177">
<property type="term" value="P:positive regulation of Wnt signaling pathway"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0009791">
<property type="term" value="P:post-embryonic development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060527">
<property type="term" value="P:prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060523">
<property type="term" value="P:prostate epithelial cord elongation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060512">
<property type="term" value="P:prostate gland morphogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046777">
<property type="term" value="P:protein autophosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0021860">
<property type="term" value="P:pyramidal neuron development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060687">
<property type="term" value="P:regulation of branching involved in prostate gland morphogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010453">
<property type="term" value="P:regulation of cell fate commitment"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070372">
<property type="term" value="P:regulation of ERK1 and ERK2 cascade"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0040036">
<property type="term" value="P:regulation of fibroblast growth factor receptor signaling pathway"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060688">
<property type="term" value="P:regulation of morphogenesis of a branching structure"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0040014">
<property type="term" value="P:regulation of multicellular organism growth"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045667">
<property type="term" value="P:regulation of osteoblast differentiation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0033688">
<property type="term" value="P:regulation of osteoblast proliferation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0014066">
<property type="term" value="P:regulation of phosphatidylinositol 3-kinase signaling"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0051150">
<property type="term" value="P:regulation of smooth muscle cell differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008589">
<property type="term" value="P:regulation of smoothened signaling pathway"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048608">
<property type="term" value="P:reproductive structure development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048705">
<property type="term" value="P:skeletal system morphogenesis"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060529">
<property type="term" value="P:squamous basal epithelial stem cell differentiation involved in prostate gland acinus development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001657">
<property type="term" value="P:ureteric bud development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0055010">
<property type="term" value="P:ventricular cardiac muscle tissue morphogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0021847">
<property type="term" value="P:ventricular zone neuroblast division"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.10">
<property type="match status" value="3"/>
</dbReference>
<dbReference type="InterPro" id="IPR028175">
<property type="entry name" value="FGF_rcpt_2"/>
</dbReference>
<dbReference type="InterPro" id="IPR016248">
<property type="entry name" value="FGF_rcpt_fam"/>
</dbReference>
<dbReference type="InterPro" id="IPR007110">
<property type="entry name" value="Ig-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR013783">
<property type="entry name" value="Ig-like_fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR013098">
<property type="entry name" value="Ig_I-set"/>
</dbReference>
<dbReference type="InterPro" id="IPR003599">
<property type="entry name" value="Ig_sub"/>
</dbReference>
<dbReference type="InterPro" id="IPR003598">
<property type="entry name" value="Ig_sub2"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR000719">
<property type="entry name" value="Prot_kinase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR017441">
<property type="entry name" value="Protein_kinase_ATP_BS"/>
</dbReference>
<dbReference type="InterPro" id="IPR001245">
<property type="entry name" value="Ser-Thr/Tyr_kinase_cat_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR008266">
<property type="entry name" value="Tyr_kinase_AS"/>
</dbReference>
<dbReference type="InterPro" id="IPR020635">
<property type="entry name" value="Tyr_kinase_cat_dom"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR24416:SF468">
<property type="entry name" value="PTHR24416:SF468"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF07679">
<property type="entry name" value="I-set"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Pfam" id="PF07714">
<property type="entry name" value="Pkinase_Tyr"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF000628">
<property type="entry name" value="FGFR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00109">
<property type="entry name" value="TYRKINASE"/>
</dbReference>
<dbReference type="SMART" id="SM00409">
<property type="entry name" value="IG"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="SMART" id="SM00408">
<property type="entry name" value="IGc2"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="SMART" id="SM00219">
<property type="entry name" value="TyrKc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48726">
<property type="entry name" value="SSF48726"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50835">
<property type="entry name" value="IG_LIKE"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="PROSITE" id="PS00107">
<property type="entry name" value="PROTEIN_KINASE_ATP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50011">
<property type="entry name" value="PROTEIN_KINASE_DOM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00109">
<property type="entry name" value="PROTEIN_KINASE_TYR"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0053">Apoptosis</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0989">Craniosynostosis</keyword>
<keyword id="KW-0968">Cytoplasmic vesicle</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0038">Ectodermal dysplasia</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0333">Golgi apparatus</keyword>
<keyword id="KW-0358">Heparin-binding</keyword>
<keyword id="KW-0393">Immunoglobulin domain</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0953">Lacrimo-auriculo-dento-digital syndrome</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0991">Mental retardation</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0656">Proto-oncogene</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0964">Secreted</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<keyword id="KW-0829">Tyrosine-protein kinase</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="signal peptide" evidence="19">
<location>
<begin position="1"/>
<end position="21"/>
</location>
</feature>
<feature type="chain" description="Fibroblast growth factor receptor 2" id="PRO_0000016783">
<location>
<begin position="22"/>
<end position="821"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="19">
<location>
<begin position="22"/>
<end position="377"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="19">
<location>
<begin position="378"/>
<end position="398"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="19">
<location>
<begin position="399"/>
<end position="821"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 1">
<location>
<begin position="25"/>
<end position="125"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 2">
<location>
<begin position="154"/>
<end position="247"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 3">
<location>
<begin position="256"/>
<end position="358"/>
</location>
</feature>
<feature type="domain" description="Protein kinase" evidence="21">
<location>
<begin position="481"/>
<end position="770"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="21 55">
<location>
<begin position="487"/>
<end position="495"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="21 55">
<location>
<begin position="565"/>
<end position="567"/>
</location>
</feature>
<feature type="region of interest" description="Heparin-binding">
<location>
<begin position="161"/>
<end position="178"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="21 22 55">
<location>
<position position="626"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="21 55">
<location>
<position position="517"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="21 55">
<location>
<position position="571"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="55 58">
<location>
<position position="466"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="52 55 58">
<location>
<position position="586"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="55 58">
<location>
<position position="588"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="52 55 58">
<location>
<position position="656"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="52 55 58">
<location>
<position position="657"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="42 55">
<location>
<position position="769"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="17">
<location>
<position position="780"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="19">
<location>
<position position="83"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="19">
<location>
<position position="123"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="19">
<location>
<position position="228"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="19">
<location>
<position position="241"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="19">
<location>
<position position="265"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="19">
<location>
<position position="297"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="19">
<location>
<position position="318"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="19">
<location>
<position position="331"/>
</location>
</feature>
<feature type="disulfide bond" evidence="20">
<location>
<begin position="62"/>
<end position="107"/>
</location>
</feature>
<feature type="disulfide bond" evidence="20 44">
<location>
<begin position="179"/>
<end position="231"/>
</location>
</feature>
<feature type="disulfide bond" evidence="20 44">
<location>
<begin position="278"/>
<end position="342"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 20." id="VSP_019608" evidence="95">
<original>EPPTKYQISQPEVYVAAPGESLEVRCLLKDAAVISWTKDGVHLGPNNRTVLIGEYLQIKGATPRDSGLYACTASRTVDSETWYFMVNVTDAISSGDDEDDTDGAEDFVSENSNNKR</original>
<variation>G</variation>
<location>
<begin position="37"/>
<end position="152"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4, isoform 21 and isoform 22." id="VSP_002964" evidence="94 98">
<location>
<begin position="37"/>
<end position="125"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 23." id="VSP_041914" evidence="100">
<location>
<begin position="250"/>
<end position="361"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 14." id="VSP_002965" evidence="92">
<original>ERSPH</original>
<variation>GSQGL</variation>
<location>
<begin position="250"/>
<end position="254"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 14." id="VSP_002966" evidence="92">
<location>
<begin position="255"/>
<end position="821"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 16." id="VSP_002967" evidence="97">
<original>K</original>
<variation>KVTK</variation>
<location>
<position position="313"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 15." id="VSP_002968" evidence="92">
<location>
<begin position="314"/>
<end position="429"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3, isoform 4, isoform 7, isoform 9, isoform 10, isoform 11, isoform 12, isoform 13, isoform 17, isoform 18, isoform 19 and isoform 22." id="VSP_002969" evidence="90 91 93 96 98 99">
<original>AAGVNTTDKEIEVLYIR</original>
<variation>HSGINSSNAEVLALF</variation>
<location>
<begin position="314"/>
<end position="330"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3, isoform 4, isoform 7, isoform 9, isoform 10, isoform 11, isoform 12, isoform 13, isoform 17, isoform 18, isoform 19 and isoform 22." id="VSP_002970" evidence="90 91 93 96 98 99">
<original>FE</original>
<variation>EA</variation>
<location>
<begin position="334"/>
<end position="335"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3, isoform 4, isoform 7, isoform 9, isoform 10, isoform 11, isoform 12, isoform 13, isoform 17, isoform 18, isoform 19 and isoform 22." id="VSP_002971" evidence="90 91 93 96 98 99">
<original>TCLAGNSIGISFH</original>
<variation>ICKVSNYIGQANQ</variation>
<location>
<begin position="341"/>
<end position="353"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3, isoform 4, isoform 7, isoform 9, isoform 10, isoform 11, isoform 12, isoform 13, isoform 17, isoform 18, isoform 19 and isoform 22." id="VSP_002972" evidence="90 91 93 96 98 99">
<original>P</original>
<variation>PKQQ</variation>
<location>
<position position="361"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 19." id="VSP_002973" evidence="91 99">
<original>APGR</original>
<variation>GRRC</variation>
<location>
<begin position="362"/>
<end position="365"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 19." id="VSP_002974" evidence="91 99">
<location>
<begin position="366"/>
<end position="821"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4, isoform 5, isoform 6, isoform 8, isoform 16 and isoform 18." id="VSP_002975" evidence="92 97 98">
<location>
<begin position="428"/>
<end position="429"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 20." id="VSP_019609" evidence="95">
<location>
<begin position="429"/>
<end position="430"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_002976" evidence="98">
<original>LTLTTNEEYLDLSQPLEQYSPSYPDTRSSCSSGDDSVFSPDPMPYEPCLPQYPHINGSVKT</original>
<variation>PPNPSLMSIFRK</variation>
<location>
<begin position="761"/>
<end position="821"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 10." id="VSP_002981" evidence="90">
<original>EYLDLSQPLEQYSPSYPDTRSSCSSGDDSVFSPDPMPYEPCLPQYPHINGSVKT</original>
<variation>SFQSSLKSSSTGIPGWPPGSEVFSEVAFRGILNYDIERPILCAGSKKIYDI</variation>
<location>
<begin position="768"/>
<end position="821"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 11." id="VSP_002982" evidence="90">
<original>EYLDLSQPLEQYSPSYPDTRSSCSSGDDSVFSPDPMPYEPCLPQYPHINGSVKT</original>
<variation>GRLPAWASQEKENSQTSLFAISHVTLSSISKTRSSAKRDEKPGSSPHLALVRSQGLPQSVVP</variation>
<location>
<begin position="768"/>
<end position="821"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 12." id="VSP_002983" evidence="90">
<original>EYLDLSQPLEQYSPSYPDTRSSCSSGDDSVFSPDPMPYEPCLPQYPHINGSVKT</original>
<variation>PLS</variation>
<location>
<begin position="768"/>
<end position="821"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 13." id="VSP_002977" evidence="90">
<location>
<begin position="768"/>
<end position="821"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2, isoform 8, isoform 17 and isoform 22." id="VSP_002978" evidence="96">
<original>EYLDLSQPLEQYSPSYPDTRSSCSSGDDSVFSPDPMPYEPCLPQYPHINGSVKT</original>
<variation>I</variation>
<location>
<begin position="768"/>
<end position="821"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 7." id="VSP_002979" evidence="90">
<original>EYLDLSQPLEQYSPSYPDTRSSCSSGDDSVFSPDPMPYEPCLPQYPHINGSVKT</original>
<variation>RYKLLPCPDKHNKRCKPEERGDLTEAGAAGSSRCVDSRKRVRQEKISTG</variation>
<location>
<begin position="768"/>
<end position="821"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 9." id="VSP_002980" evidence="90">
<original>EYLDLSQPLEQYSPSYPDTRSSCSSGDDSVFSPDPMPYEPCLPQYPHINGSVKT</original>
<variation>RILTLTTNENFQSTSGREGTEIHALQCLRSEVTPAISCESPLADTGSKVPN</variation>
<location>
<begin position="768"/>
<end position="821"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 21." id="VSP_041915" evidence="94">
<original>YLDLSQPLEQYSPSYPDTRSSCSSGDDSVFSPDPMPYEPCLPQYPHINGSVKT</original>
<variation>EKKVSGAVDCHKPPCNPSHLPCVLAVDQ</variation>
<location>
<begin position="769"/>
<end position="821"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 6." id="VSP_002984" evidence="101">
<original>QYSPSYPDTRSSCSSGDDSVFSPDPMPYEPCLPQYPHINGSVKT</original>
<variation>PYSPCYPDPR</variation>
<location>
<begin position="778"/>
<end position="821"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs3750819." id="VAR_017258" evidence="89">
<original>R</original>
<variation>P</variation>
<location>
<position position="6"/>
</location>
</feature>
<feature type="sequence variant" description="Polymorphism; dbSNP:rs56226109." id="VAR_042204" evidence="50 62">
<original>S</original>
<variation>L</variation>
<location>
<position position="57"/>
</location>
</feature>
<feature type="sequence variant" description="In CS." id="VAR_004112" evidence="35 75">
<original>Y</original>
<variation>C</variation>
<location>
<position position="105"/>
</location>
</feature>
<feature type="sequence variant" description="In PS; requires 2 nucleotide substitutions." id="VAR_017259" evidence="35">
<original>A</original>
<variation>F</variation>
<location>
<position position="172"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs755793." id="VAR_017260" evidence="35 50 89">
<original>M</original>
<variation>T</variation>
<location>
<position position="186"/>
</location>
</feature>
<feature type="sequence variant" description="In breast cancer samples; infiltrating ductal carcinoma; somatic mutation." id="VAR_036380" evidence="48 50">
<original>R</original>
<variation>C</variation>
<location>
<position position="203"/>
</location>
</feature>
<feature type="sequence variant" description="In PS; dbSNP:rs281865420." id="VAR_004116">
<original>SP</original>
<variation>FS</variation>
<location>
<begin position="252"/>
<end position="253"/>
</location>
</feature>
<feature type="sequence variant" description="In APRS; requires 2 nucleotide substitutions; dbSNP:rs121918498." id="VAR_004114" evidence="78">
<original>S</original>
<variation>F</variation>
<location>
<position position="252"/>
</location>
</feature>
<feature type="sequence variant" description="In CS; dbSNP:rs79184941." id="VAR_004113" evidence="78">
<original>S</original>
<variation>L</variation>
<location>
<position position="252"/>
</location>
</feature>
<feature type="sequence variant" description="In APRS and PS; common mutation; dbSNP:rs79184941." id="VAR_004115" evidence="35 41 65 67 82 85 87">
<original>S</original>
<variation>W</variation>
<location>
<position position="252"/>
</location>
</feature>
<feature type="sequence variant" description="In APRS; common mutation; dbSNP:rs77543610." id="VAR_004117" evidence="35 65 67 82 85">
<original>P</original>
<variation>R</variation>
<location>
<position position="253"/>
</location>
</feature>
<feature type="sequence variant" description="In CS; dbSNP:rs779326224." id="VAR_017261" evidence="32">
<original>P</original>
<variation>L</variation>
<location>
<position position="263"/>
</location>
</feature>
<feature type="sequence variant" description="In CS; dbSNP:rs121918505." id="VAR_004118" evidence="35">
<original>S</original>
<variation>P</variation>
<location>
<position position="267"/>
</location>
</feature>
<feature type="sequence variant" description="In CS." id="VAR_004119" evidence="72">
<original>T</original>
<variation>TG</variation>
<location>
<position position="268"/>
</location>
</feature>
<feature type="sequence variant" description="In SCS." id="VAR_075856" evidence="84">
<location>
<begin position="269"/>
<end position="270"/>
</location>
</feature>
<feature type="sequence variant" description="In an ovarian serous carcinoma sample; somatic mutation." id="VAR_042205" evidence="50">
<original>G</original>
<variation>V</variation>
<location>
<position position="272"/>
</location>
</feature>
<feature type="sequence variant" description="In PS; type 2." id="VAR_017262" evidence="29">
<location>
<position position="273"/>
</location>
</feature>
<feature type="sequence variant" description="In CS." id="VAR_004120" evidence="32 35 83">
<original>F</original>
<variation>V</variation>
<location>
<position position="276"/>
</location>
</feature>
<feature type="sequence variant" description="In CS, JWS and PS; forms disulfide-linked dimers with constitutive kinase activity, is retained in an intracellular compartment and not detected at the cell surface; dbSNP:rs776587763." id="VAR_004121" evidence="32 35 47 72 85">
<original>C</original>
<variation>F</variation>
<location>
<position position="278"/>
</location>
</feature>
<feature type="sequence variant" description="In CS." id="VAR_017263" evidence="32">
<original>C</original>
<variation>Y</variation>
<location>
<position position="278"/>
</location>
</feature>
<feature type="sequence variant" description="In CS." id="VAR_017264" evidence="33 35">
<original>Y</original>
<variation>C</variation>
<location>
<position position="281"/>
</location>
</feature>
<feature type="sequence variant" description="In a lung squamous cell carcinoma sample; somatic mutation." id="VAR_042206" evidence="50">
<original>D</original>
<variation>N</variation>
<location>
<position position="283"/>
</location>
</feature>
<feature type="sequence variant" description="In CS." id="VAR_004122">
<location>
<begin position="287"/>
<end position="289"/>
</location>
</feature>
<feature type="sequence variant" description="In CS." id="VAR_017265" evidence="32">
<original>I</original>
<variation>S</variation>
<location>
<position position="288"/>
</location>
</feature>
<feature type="sequence variant" description="In CS and JWS; dbSNP:rs121918497." id="VAR_004123" evidence="32 33 35 63 72">
<original>Q</original>
<variation>P</variation>
<location>
<position position="289"/>
</location>
</feature>
<feature type="sequence variant" description="In PS; severe; also in a lung squamous cell carcinoma sample; somatic mutation; dbSNP:rs121918499." id="VAR_004124" evidence="35 50 79">
<original>W</original>
<variation>C</variation>
<location>
<position position="290"/>
</location>
</feature>
<feature type="sequence variant" description="In CS; dbSNP:rs121918501." id="VAR_017266" evidence="71">
<original>W</original>
<variation>G</variation>
<location>
<position position="290"/>
</location>
</feature>
<feature type="sequence variant" description="In CS; dbSNP:rs121918501." id="VAR_004125">
<original>W</original>
<variation>R</variation>
<location>
<position position="290"/>
</location>
</feature>
<feature type="sequence variant" description="In CS; dbSNP:rs121918500." id="VAR_004126" evidence="80">
<original>K</original>
<variation>E</variation>
<location>
<position position="292"/>
</location>
</feature>
<feature type="sequence variant" description="In CS." id="VAR_004127" evidence="83">
<original>Y</original>
<variation>C</variation>
<location>
<position position="301"/>
</location>
</feature>
<feature type="sequence variant" description="In craniosynostosis." id="VAR_004128" evidence="83">
<original>A</original>
<variation>S</variation>
<location>
<position position="314"/>
</location>
</feature>
<feature type="sequence variant" description="In a non-syndromic craniosynostosis patient with abnormal intrauterine history; confers predisposition to craniosynostosis; dbSNP:rs121918504." id="VAR_017267" evidence="30 35">
<original>A</original>
<variation>S</variation>
<location>
<position position="315"/>
</location>
</feature>
<feature type="sequence variant" description="In PS; dbSNP:rs121918510." id="VAR_004129" evidence="66">
<original>D</original>
<variation>A</variation>
<location>
<position position="321"/>
</location>
</feature>
<feature type="sequence variant" description="In CS; dbSNP:rs121918493." id="VAR_004130" evidence="69">
<original>Y</original>
<variation>C</variation>
<location>
<position position="328"/>
</location>
</feature>
<feature type="sequence variant" description="In CS." id="VAR_004131" evidence="76">
<original>N</original>
<variation>I</variation>
<location>
<position position="331"/>
</location>
</feature>
<feature type="sequence variant" description="In CS." id="VAR_004132">
<original>A</original>
<variation>ANA</variation>
<location>
<position position="337"/>
</location>
</feature>
<feature type="sequence variant" description="In CS; dbSNP:rs387906676." id="VAR_017268" evidence="85">
<original>A</original>
<variation>P</variation>
<location>
<position position="337"/>
</location>
</feature>
<feature type="sequence variant" description="In CS." id="VAR_004133" evidence="75">
<original>G</original>
<variation>E</variation>
<location>
<position position="338"/>
</location>
</feature>
<feature type="sequence variant" description="In CS." id="VAR_015011" evidence="35 63 85">
<original>G</original>
<variation>R</variation>
<location>
<position position="338"/>
</location>
</feature>
<feature type="sequence variant" description="In PS." id="VAR_017269" evidence="23 35">
<original>Y</original>
<variation>C</variation>
<location>
<position position="340"/>
</location>
</feature>
<feature type="sequence variant" description="In CS; dbSNP:rs121918489." id="VAR_004134" evidence="35 70">
<original>Y</original>
<variation>H</variation>
<location>
<position position="340"/>
</location>
</feature>
<feature type="sequence variant" description="In PS and CS; dbSNP:rs121918495." id="VAR_004135" evidence="32 35 68">
<original>T</original>
<variation>P</variation>
<location>
<position position="341"/>
</location>
</feature>
<feature type="sequence variant" description="In CS." id="VAR_004136" evidence="35 72 85">
<original>C</original>
<variation>F</variation>
<location>
<position position="342"/>
</location>
</feature>
<feature type="sequence variant" description="In PS." id="VAR_017270" evidence="23">
<original>C</original>
<variation>G</variation>
<location>
<position position="342"/>
</location>
</feature>
<feature type="sequence variant" description="In CS, JWS, PS and ABS2; dbSNP:rs121918488." id="VAR_004137" evidence="27 32 33 35 68 70 71 72 85">
<original>C</original>
<variation>R</variation>
<location>
<position position="342"/>
</location>
</feature>
<feature type="sequence variant" description="In CS, JWS, PS and ABS2; dbSNP:rs121918488." id="VAR_004138" evidence="27 32 35 63 70 72 81 88">
<original>C</original>
<variation>S</variation>
<location>
<position position="342"/>
</location>
</feature>
<feature type="sequence variant" description="In CS; dbSNP:rs121918496." id="VAR_017271" evidence="32 35 71">
<original>C</original>
<variation>W</variation>
<location>
<position position="342"/>
</location>
</feature>
<feature type="sequence variant" description="In CS and PS; dbSNP:rs121918487." id="VAR_004139" evidence="32 33 35 63 68 70 72 85">
<original>C</original>
<variation>Y</variation>
<location>
<position position="342"/>
</location>
</feature>
<feature type="sequence variant" description="In CS and JWS; dbSNP:rs121918492." id="VAR_004140" evidence="63 69">
<original>A</original>
<variation>G</variation>
<location>
<position position="344"/>
</location>
</feature>
<feature type="sequence variant" description="In CS and PS." id="VAR_004141" evidence="72">
<original>A</original>
<variation>P</variation>
<location>
<position position="344"/>
</location>
</feature>
<feature type="sequence variant" description="In CS; dbSNP:rs121918494." id="VAR_004142" evidence="35 69">
<original>S</original>
<variation>C</variation>
<location>
<position position="347"/>
</location>
</feature>
<feature type="sequence variant" description="In CS, PS and ABS2; dbSNP:rs121918502." id="VAR_004143" evidence="27 75 86">
<original>S</original>
<variation>C</variation>
<location>
<position position="351"/>
</location>
</feature>
<feature type="sequence variant" description="In CS; dbSNP:rs121918490." id="VAR_004144" evidence="32 35 63 70 71">
<original>S</original>
<variation>C</variation>
<location>
<position position="354"/>
</location>
</feature>
<feature type="sequence variant" description="In CS." id="VAR_017272" evidence="32">
<original>S</original>
<variation>Y</variation>
<location>
<position position="354"/>
</location>
</feature>
<feature type="sequence variant" description="In CS." id="VAR_004145" evidence="76">
<location>
<begin position="356"/>
<end position="358"/>
</location>
</feature>
<feature type="sequence variant" description="In CS and PS." id="VAR_004146" evidence="32 72">
<original>V</original>
<variation>F</variation>
<location>
<position position="359"/>
</location>
</feature>
<feature type="sequence variant" description="In CS." id="VAR_017273" evidence="24">
<original>A</original>
<variation>S</variation>
<location>
<position position="362"/>
</location>
</feature>
<feature type="sequence variant" description="In BSTVS; dbSNP:rs121913477." id="VAR_017274" evidence="74">
<original>S</original>
<variation>C</variation>
<location>
<position position="372"/>
</location>
</feature>
<feature type="sequence variant" description="In PS and BSTVS; dbSNP:rs121913478." id="VAR_017275" evidence="35 36 74">
<original>Y</original>
<variation>C</variation>
<location>
<position position="375"/>
</location>
</feature>
<feature type="sequence variant" description="In BBDS; dbSNP:rs387906678." id="VAR_067977" evidence="61">
<original>Y</original>
<variation>D</variation>
<location>
<position position="381"/>
</location>
</feature>
<feature type="sequence variant" description="In CS." id="VAR_004147" evidence="75">
<original>G</original>
<variation>R</variation>
<location>
<position position="384"/>
</location>
</feature>
<feature type="sequence variant" description="In BBDS; the mutation selectively reduces plasma-membrane levels of the protein and markedly diminishes the receptor's responsiveness to extracellular FGF; dbSNP:rs387906677." id="VAR_067978" evidence="61">
<original>M</original>
<variation>R</variation>
<location>
<position position="391"/>
</location>
</feature>
<feature type="sequence variant" description="In FSPC; constitutive kinase activity; dbSNP:rs121918507." id="VAR_023788" evidence="43 52">
<original>K</original>
<variation>E</variation>
<location>
<position position="526"/>
</location>
</feature>
<feature type="sequence variant" description="In CS; constitutive kinase activity." id="VAR_017276" evidence="35 52">
<original>N</original>
<variation>H</variation>
<location>
<position position="549"/>
</location>
</feature>
<feature type="sequence variant" description="In PS; constitutive kinase activity." id="VAR_017277" evidence="35 52">
<original>E</original>
<variation>G</variation>
<location>
<position position="565"/>
</location>
</feature>
<feature type="sequence variant" description="In a lung adenocarcinoma sample; somatic mutation." id="VAR_046071" evidence="50">
<original>R</original>
<variation>T</variation>
<location>
<position position="612"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_015012" evidence="26 39">
<original>G</original>
<variation>R</variation>
<location>
<position position="613"/>
</location>
</feature>
<feature type="sequence variant" description="In LADDS; strongly reduced kinase activity; dbSNP:rs121918509." id="VAR_029884" evidence="45">
<original>A</original>
<variation>T</variation>
<location>
<position position="628"/>
</location>
</feature>
<feature type="sequence variant" description="In PS; constitutive kinase activity." id="VAR_017278" evidence="35 52">
<original>K</original>
<variation>R</variation>
<location>
<position position="641"/>
</location>
</feature>
<feature type="sequence variant" description="In LADDS; dbSNP:rs121918508." id="VAR_029885" evidence="45">
<original>A</original>
<variation>T</variation>
<location>
<position position="648"/>
</location>
</feature>
<feature type="sequence variant" description="In LADDS." id="VAR_029886" evidence="45">
<original>RD</original>
<variation>S</variation>
<location>
<begin position="649"/>
<end position="650"/>
</location>
</feature>
<feature type="sequence variant" description="In craniosynostosis; constitutive kinase activity." id="VAR_017279" evidence="35 52">
<original>K</original>
<variation>N</variation>
<location>
<position position="659"/>
</location>
</feature>
<feature type="sequence variant" description="In PS." id="VAR_017280" evidence="35">
<original>G</original>
<variation>E</variation>
<location>
<position position="663"/>
</location>
</feature>
<feature type="sequence variant" description="In CS." id="VAR_017281" evidence="35">
<original>R</original>
<variation>G</variation>
<location>
<position position="678"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced N-glycosylation. Reduced expression at the cell surface." evidence="47">
<original>N</original>
<variation>Q</variation>
<location>
<position position="265"/>
</location>
</feature>
<feature type="mutagenesis site" description="Constitutive kinase activity." evidence="52">
<original>N</original>
<variation>T</variation>
<location>
<position position="549"/>
</location>
</feature>
<feature type="mutagenesis site" description="Constitutive kinase activity." evidence="52">
<original>E</original>
<variation>A</variation>
<location>
<position position="565"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of kinase activity." evidence="47">
<location>
<begin position="656"/>
<end position="657"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increases fibroblast proliferation. Decreases phosphorylation of PLCG1 and FRS2. Decreases activation of MAP kinases." evidence="42 56">
<original>Y</original>
<variation>F</variation>
<location>
<position position="769"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 16; BAG57383." ref="16" evidence="101">
<original>L</original>
<variation>P</variation>
<location>
<position position="246"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 16; BAG57383." ref="16" evidence="101">
<original>K</original>
<variation>N</variation>
<location>
<position position="310"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="152"/>
<end position="157"/>
</location>
</feature>
<feature type="turn" evidence="9">
<location>
<begin position="159"/>
<end position="162"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="166"/>
<end position="170"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="175"/>
<end position="178"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="181"/>
<end position="185"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="188"/>
<end position="193"/>
</location>
</feature>
<feature type="helix" evidence="9">
<location>
<begin position="200"/>
<end position="202"/>
</location>
</feature>
<feature type="strand" evidence="14">
<location>
<begin position="203"/>
<end position="205"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="208"/>
<end position="210"/>
</location>
</feature>
<feature type="helix" evidence="9">
<location>
<begin position="211"/>
<end position="213"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="215"/>
<end position="218"/>
</location>
</feature>
<feature type="helix" evidence="9">
<location>
<begin position="223"/>
<end position="225"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="227"/>
<end position="235"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="238"/>
<end position="249"/>
</location>
</feature>
<feature type="strand" evidence="12">
<location>
<begin position="266"/>
<end position="269"/>
</location>
</feature>
<feature type="strand" evidence="12">
<location>
<begin position="274"/>
<end position="277"/>
</location>
</feature>
<feature type="strand" evidence="12">
<location>
<begin position="287"/>
<end position="293"/>
</location>
</feature>
<feature type="strand" evidence="11">
<location>
<begin position="296"/>
<end position="298"/>
</location>
</feature>
<feature type="strand" evidence="12">
<location>
<begin position="299"/>
<end position="301"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="303"/>
<end position="305"/>
</location>
</feature>
<feature type="strand" evidence="12">
<location>
<begin position="309"/>
<end position="313"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="315"/>
<end position="319"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="321"/>
<end position="325"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="326"/>
<end position="329"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="334"/>
<end position="336"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="338"/>
<end position="345"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="350"/>
<end position="357"/>
</location>
</feature>
<feature type="turn" evidence="16">
<location>
<begin position="463"/>
<end position="465"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="472"/>
<end position="474"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="478"/>
<end position="480"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="481"/>
<end position="489"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="494"/>
<end position="500"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="504"/>
<end position="506"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="513"/>
<end position="518"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="525"/>
<end position="541"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="550"/>
<end position="554"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="556"/>
<end position="558"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="561"/>
<end position="565"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="568"/>
<end position="571"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="572"/>
<end position="577"/>
</location>
</feature>
<feature type="turn" evidence="13">
<location>
<begin position="585"/>
<end position="588"/>
</location>
</feature>
<feature type="helix" evidence="16">
<location>
<begin position="594"/>
<end position="596"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="600"/>
<end position="619"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="629"/>
<end position="631"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="632"/>
<end position="634"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="636"/>
<end position="638"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="640"/>
<end position="642"/>
</location>
</feature>
<feature type="helix" evidence="15">
<location>
<begin position="645"/>
<end position="647"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="652"/>
<end position="654"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="655"/>
<end position="658"/>
</location>
</feature>
<feature type="turn" evidence="8">
<location>
<begin position="659"/>
<end position="662"/>
</location>
</feature>
<feature type="strand" evidence="16">
<location>
<begin position="664"/>
<end position="666"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="667"/>
<end position="669"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="672"/>
<end position="677"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="682"/>
<end position="697"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="709"/>
<end position="718"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="726"/>
<end position="728"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="730"/>
<end position="739"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="744"/>
<end position="746"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="750"/>
<end position="764"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1EV2"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1IIL"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1OEC"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2FDB"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2PVF"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2PVY"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2PZ5"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2PZR"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3CAF"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3CLY"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3OJ2"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3OJM"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4J99"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4WV1"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5UGL"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5UI0"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P21803"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000255"/>
<evidence key="20" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00114"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00159"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU10028"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10394936"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10574673"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10618369"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10626794"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10633130"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10830168"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10945669"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10951518"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11069186"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11173845"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11380921"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11390973"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11781872"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12000365"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12529371"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12591959"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1309608"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1400433"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15190072"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15629145"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16061565"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16384934"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16501574"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16597617"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16844695"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16959974"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17311277"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17344846"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17623664"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17803937"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18056630"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18374639"/>
</source>
</evidence>
<evidence key="55" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19060208"/>
</source>
</evidence>
<evidence key="56" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19103595"/>
</source>
</evidence>
<evidence key="57" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19387476"/>
</source>
</evidence>
<evidence key="58" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19410646"/>
</source>
</evidence>
<evidence key="59" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21454610"/>
</source>
</evidence>
<evidence key="60" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21596750"/>
</source>
</evidence>
<evidence key="61" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22387015"/>
</source>
</evidence>
<evidence key="62" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26429889"/>
</source>
</evidence>
<evidence key="63" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7581378"/>
</source>
</evidence>
<evidence key="64" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7655462"/>
</source>
</evidence>
<evidence key="65" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7668257"/>
</source>
</evidence>
<evidence key="66" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7719333"/>
</source>
</evidence>
<evidence key="67" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7719344"/>
</source>
</evidence>
<evidence key="68" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7719345"/>
</source>
</evidence>
<evidence key="69" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7874170"/>
</source>
</evidence>
<evidence key="70" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7987400"/>
</source>
</evidence>
<evidence key="71" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8528214"/>
</source>
</evidence>
<evidence key="72" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8644708"/>
</source>
</evidence>
<evidence key="73" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8663044"/>
</source>
</evidence>
<evidence key="74" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8696350"/>
</source>
</evidence>
<evidence key="75" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8946174"/>
</source>
</evidence>
<evidence key="76" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8956050"/>
</source>
</evidence>
<evidence key="77" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8961926"/>
</source>
</evidence>
<evidence key="78" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9002682"/>
</source>
</evidence>
<evidence key="79" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9150725"/>
</source>
</evidence>
<evidence key="80" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9152842"/>
</source>
</evidence>
<evidence key="81" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9385368"/>
</source>
</evidence>
<evidence key="82" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9452027"/>
</source>
</evidence>
<evidence key="83" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9521581"/>
</source>
</evidence>
<evidence key="84" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9585583"/>
</source>
</evidence>
<evidence key="85" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9677057"/>
</source>
</evidence>
<evidence key="86" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9693549"/>
</source>
</evidence>
<evidence key="87" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9719378"/>
</source>
</evidence>
<evidence key="88" type="ECO:0000269">
<source ref="10"/>
</evidence>
<evidence key="89" type="ECO:0000269">
<source ref="15"/>
</evidence>
<evidence key="90" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="10626794"/>
</source>
</evidence>
<evidence key="91" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="1309608"/>
</source>
</evidence>
<evidence key="92" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="1313574"/>
</source>
</evidence>
<evidence key="93" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="1400433"/>
</source>
</evidence>
<evidence key="94" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="95" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="96" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="1647213"/>
</source>
</evidence>
<evidence key="97" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="2172978"/>
</source>
</evidence>
<evidence key="98" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="2377625"/>
</source>
</evidence>
<evidence key="99" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="7866434"/>
</source>
</evidence>
<evidence key="100" type="ECO:0000303">
<source ref="14"/>
</evidence>
<evidence key="101" type="ECO:0000305"/>
<sequence length="821" mass="92025" checksum="6CD5001C960ED82F" modified="1991-05-01" version="1" precursor="true">
MVSWGRFICLVVVTMATLSLARPSFSLVEDTTLEPEEPPTKYQISQPEVYVAAPGESLEV
RCLLKDAAVISWTKDGVHLGPNNRTVLIGEYLQIKGATPRDSGLYACTASRTVDSETWYF
MVNVTDAISSGDDEDDTDGAEDFVSENSNNKRAPYWTNTEKMEKRLHAVPAANTVKFRCP
AGGNPMPTMRWLKNGKEFKQEHRIGGYKVRNQHWSLIMESVVPSDKGNYTCVVENEYGSI
NHTYHLDVVERSPHRPILQAGLPANASTVVGGDVEFVCKVYSDAQPHIQWIKHVEKNGSK
YGPDGLPYLKVLKAAGVNTTDKEIEVLYIRNVTFEDAGEYTCLAGNSIGISFHSAWLTVL
PAPGREKEITASPDYLEIAIYCIGVFLIACMVVTVILCRMKNTTKKPDFSSQPAVHKLTK
RIPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDK
LTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKM
IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF
KDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT
TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGH
RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEEYLDLSQPLEQYS
PSYPDTRSSCSSGDDSVFSPDPMPYEPCLPQYPHINGSVKT
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>